10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

(Mark One)

x              QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d)

OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended March 31, 2013

or

o               TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

For the transition period from _______________ to _______________

Commission file number 1-11316

OMEGA HEALTHCARE

INVESTORS, INC.

(Exact name of Registrant as specified in its charter)
Maryland	38-3041398
(State of incorporation)	(IRS Employer Identification No.)
200 International Circle, Suite 3500, Hunt Valley, MD 21030
(Address of principal executive offices)
(410) 427-1700
(Telephone number, including area code)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports) and (2) has been subject to such filing requirements for the past 90 days.

Yes   x                                           No   o

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).

Yes    x                                           No   o

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, or non-accelerated filer.  See definition of “accelerated filer and large accelerated filer” in Rule 12b-2 of the Exchange Act.  (Check one:)

Large accelerated filer   x                               Accelerated filer   o                             Non-accelerated filer   o             Smaller reporting company   o

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

Yes   o                                                      No   x

Indicate the number of shares outstanding of each of the issuer’s classes of common stock as of May 3, 2013.

Common Stock, $.10 par value	116,154,455
(Class)	(Number of shares)

OMEGA HEALTHCARE INVESTORS, INC.

FORM 10-Q

March 31, 2013

TABLE OF CONTENTS
		Page No.
PART I	Financial Information
Item 1.	Financial Statements:
	Consolidated Balance Sheets March 31, 2013 (unaudited) and December 31, 2012	2
	Consolidated Statements of Operations (unaudited) Three months ended March 31, 2013 and 2012	3
	Consolidated Statement of Stockholders’ Equity Three months ended March 31, 2013 (unaudited)	4
	Consolidated Statements of Cash Flows (unaudited) Three months ended March 31, 2013 and 2012	5
	Notes to Consolidated Financial Statements March 31, 2013 (unaudited)	6
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	22
Item 3.	Quantitative and Qualitative Disclosures About Market Risk	33
Item 4.	Controls and Procedures	33
PART II	Other Information
Item 1.	Legal Proceedings	34
Item 1A.	Risk Factors	34
Item 6.	Exhibits	35

PART I – FINANCIAL INFORMATION

Item 1 - Financial Statements

OMEGA HEALTHCARE INVESTORS, INC.

CONSOLIDATED BALANCE SHEETS

(in thousands, except per share amounts)

	March 31,			December 31,
	2013			2012
	(Unaudited)
ASSETS
Real estate properties
Land and buildings	$	3,046,805		$	3,038,553
Less accumulated depreciation		(612,302	)		(580,373	)
Real estate properties – net		2,434,503			2,458,180
Mortgage notes receivable – net		240,551			238,621
		2,675,054			2,696,801
Other investments – net		48,537			47,339
		2,723,591			2,744,140
Assets held for sale – net		1,020			1,020
Total investments		2,724,611			2,745,160
Cash and cash equivalents		25,611			1,711
Restricted cash		34,377			36,660
Accounts receivable – net		130,258			125,180
Other assets		89,784			73,294
Total assets	$	3,004,641		$	2,982,005
LIABILITIES AND STOCKHOLDERS’ EQUITY
Revolving line of credit	$	200,000		$	258,000
Secured borrowings		365,428			366,538
Unsecured borrowings – net		1,200,266			1,200,394
Accrued expenses and other liabilities		133,193			145,744
Total liabilities		1,898,887			1,970,676
Stockholders’ equity:
Common stock $.10 par value 200,000 shares authorized –– 116,153 shares as of March 31, 2013 and 112,393 as of December 31, 2012 issued and outstanding		11,615			11,239
Common stock – additional paid-in capital		1,771,374			1,664,855
Cumulative net earnings		792,248			754,128
Cumulative dividends paid		(1,469,483	)		(1,418,893	)
Total stockholders’ equity		1,105,754			1,011,329
Total liabilities and stockholders’ equity	$	3,004,641		$	2,982,005

See notes to consolidated financial statements.

2

OMEGA HEALTHCARE INVESTORS, INC.

CONSOLIDATED STATEMENTS OF OPERATIONS

Unaudited

(in thousands, except per share amounts)

	Three Months Ended
	March 31,
	2013			2012
Revenue
Rental income	$	93,109		$	75,975
Mortgage interest income		7,346			7,336
Other investment income – net		1,306			1,130
Miscellaneous		-			74
Total operating revenues		101,761			84,515
Expenses
Depreciation and amortization		31,959			27,147
General and administrative		5,197			5,526
Acquisition costs		134			105
Impairment loss on real estate properties		-			272
Total operating expenses		37,290			33,050
Income before other income and expense		64,471			51,465
Other income (expense)
Interest income		3			7
Interest expense		(25,672	)		(22,967	)
Interest – amortization of deferred financing costs		(682	)		(629	)
Interest – refinancing costs		-			(7,108	)
Total other expense		(26,351	)		(30,697	)
Income before gain on assets sold		38,120			20,768
Gain on assets sold – net		-			5,316
Net income available to common stockholders	$	38,120		$	26,084
Income per common share available to common shareholders:
Basic:
Net income	$	0.34		$	0.25
Diluted:
Net income	$	0.34		$	0.25
Dividends declared and paid per common share	$	0.45		$	0.41
Weighted-average shares outstanding, basic		112,782			103,754
Weighted-average shares outstanding, diluted		113,522			104,012

See notes to consolidated financial statements.

3

OMEGA HEALTHCARE INVESTORS, INC.

CONSOLIDATED STATEMENT OF STOCKHOLDERS’ EQUITY

Unaudited

(in thousands, except per share amounts)

	Common Stock Par Value		Additional Paid-in Capital			Cumulative Net Earnings		Cumulative Dividends			Total
Balance at December 31, 2012 (112,393 common shares)	$	11,239	$	1,664,855		$	754,128	$	(1,418,893	)	$	1,011,329
Issuance of common stock:
Grant of restricted stock to company directors (4 shares at $26.42 per share)		1		(1	)		—		—			—
Amortization of restricted stock		—		1,436			—		—			1,436
Dividend reinvestment plan (1,315 shares at $27.63 per share)		131		36,199			—		—			36,330
Grant of stock as payment of directors fees (1 share at an average of $27.75 per share)		—		37			—		—			37
Equity Shelf Program (2,440 shares at $28.95 per share, net of issuance costs)		244		68,848			—		—			69,092
Net income		—		—			38,120		—			38,120
Common dividends ($0.45 per share)		—		—			—		(50,590	)		(50,590	)
Balance at March 31, 2013 (116,153 common shares)	$	11,615	$	1,771,374		$	792,248	$	(1,469,483	)	$	1,105,754

See notes to consolidated financial statements.

4

OMEGA HEALTHCARE INVESTORS, INC.

CONSOLIDATED STATEMENTS OF CASH FLOWS

Unaudited (in thousands)

	Three Months Ended March 31,
	2013			2012
Cash flows from operating activities
Net income	$	38,120		$	26,084
Adjustment to reconcile net income to cash provided by operating activities:
Depreciation and amortization		31,959			27,147
Impairment on real estate properties		—			272
Amortization of deferred financing and debt extinguishment costs		682			7,737
Restricted stock amortization expense		1,452			1,485
Gain on assets sold – net		—			(5,316	)
Amortization of acquired in-place leases - net		(1,304	)		(1,426	)
Other		—			(38	)
Change in operating assets and liabilities – net of amounts assumed/acquired:
Accounts receivable, net		635			176
Straight-line rent		(6,010	)		(6,541	)
Lease inducement		842			842
Effective yield receivable on mortgage notes		(545	)		(554	)
Other operating assets and liabilities		(8,231	)		(324	)
Net cash provided by operating activities		57,600			49,544
Cash flows from investing activities
Acquisition of real estate – net of liabilities assumed and escrows acquired		—			(1,852	)
Placement of mortgage loans		(2,049	)		(1,309	)
Proceeds from sale of real estate investments		—			14,068
Capital improvements and funding of other investments		(8,328	)		(7,985	)
Proceeds from other investments		1,770			8,060
Investments in other investments		(2,968	)		(1,069	)
Collection of mortgage principal		119			119
Net cash (used in) provided by investing activities		(11,456	)		10,032
Cash flows from financing activities
Proceeds from credit facility borrowings		155,000			45,000
Payments on credit facility borrowings		(213,000	)		(290,500	)
Receipts of other long-term borrowings		59,355			400,000
Payments of other long-term borrowings		(59,997	)		(176,007	)
Payments of financing related costs		(806	)		(12,517	)
Receipts from dividend reinvestment plan		36,330			14,224
Net proceeds from issuance of common stock		51,453			5,170
Dividends paid		(50,579	)		(42,580	)
Net cash used in financing activities		(22,244	)		(57,210	)
Increase in cash and cash equivalents		23,900			2,366
Cash and cash equivalents at beginning of period		1,711			351
Cash and cash equivalents at end of period	$	25,611		$	2,717
Interest paid during the period, net of amounts capitalized	$	26,092		$	22,163

Non-cash financing activities:
	Three Months Ended March 31,
	2013		2012
Common stock subscription	$	17,639		-

See notes to consolidated financial statements.

5

OMEGA HEALTHCARE INVESTORS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

Unaudited

March 31, 2013

NOTE 1 – BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES

Business Overview

Omega Healthcare Investors, Inc. (“Omega” or the “Company”) has one reportable segment consisting of investments in healthcare-related real estate properties.  Our core business is to provide financing and capital to the long-term healthcare industry with a particular focus on skilled nursing facilities (“SNFs”) located in the United States.  Our core portfolio consists of long-term leases and mortgage agreements.  All of our leases are “triple-net” leases, which require the tenants to pay all property-related expenses.  Our mortgage revenue derives from fixed-rate mortgage loans, which are secured by first mortgage liens on the underlying real estate and personal property of the mortgagor.

Basis of Presentation

The accompanying unaudited consolidated financial statements for Omega have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”) regarding interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X.  Accordingly, they do not include all of the information and notes required by U.S. generally accepted accounting principles (“GAAP”) for complete financial statements.  In our opinion, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included. We have evaluated all subsequent events through the date of the filing of this Form 10-Q.These unaudited consolidated financial statements should be read in conjunction with the financial statements and the footnotes thereto included in our latest Annual Report on Form 10-K.

Our consolidated financial statements include the accounts of (i) Omega, (ii) all direct and indirect wholly owned subsidiaries of Omega, and (iii) TC Healthcare, a variable interest entity (“VIE”) that we consolidate as the primary beneficiary.  All inter-company accounts and transactions have been eliminated in consolidation of the financial statements.

Accounts Receivable
 

Accounts receivable includes: contractual receivables, effective yield interest receivables, straight-line rent receivables and lease inducements, net of an estimated provision for losses related to uncollectible and disputed accounts.  Contractual receivables relate to the amounts currently owed to us under the terms of our lease and loan agreements.  Effective yield interest receivables relate to the difference between the interest income recognized on an effective yield basis over the term of the loan agreement and the interest currently due to us according to the contractual agreement. Straight-line receivables relate to the difference between the rental revenue recognized on a straight-line basis and the amounts currently due to us according to the contractual agreement.  Lease inducements result from value provided by us to the lessee at the inception or renewal of the lease and will be amortized as a reduction of rental revenue over the non cancellable lease term. 

On a quarterly basis, we review our accounts receivable to determine their collectability.  The determination of collectability of these assets requires significant judgment and is affected by several factors relating to the credit quality of our operators that we regularly monitor, including (i) payment history, (ii) the age of the contractual receivables, (iii) the current economic conditions and reimbursement environment, (iv) the ability of the tenant to perform under the terms of their lease and/or contractual loan agreements and (v) the value of the underlying collateral of the agreement.  If we determine collectability of any of our contractual receivables is at risk, we estimate the potential uncollectible amounts and provide an allowance.  In the case of a lease recognized on a straight-line basis or existence of lease inducements, we generally provide an allowance for straight-line accounts receivable and/or the lease inducements when certain conditions or indicators of adverse collectability are present.

6

A summary of our net receivables by type is as follows:

	March 31, 2013			December 31, 2012
	(in thousands)
Contractual receivables	$	3,269		$	3,963
Effective yield interest receivables		4,121			3,576
Straight-line receivables		104,983			98,973
Lease inducements		18,465			19,307
Allowance		(580	)		(639	)
Accounts receivable – net	$	130,258		$	125,180

We continuously evaluate the payment history and financial strength of our operators and have historically established allowance reserves for straight-line rent adjustments for operators that do not meet our requirements.  We consider factors such as payment history and the operator’s financial condition as well as current and future anticipated operating trends when evaluating whether to establish allowance reserves.

NOTE 2 – PROPERTIES AND INVESTMENTS

In the ordinary course of our business activities, we periodically evaluate investment opportunities and extend credit to customers.  We also regularly engage in lease and/or loan extensions and modifications. Additionally, we actively monitor and manage our investment portfolio with the objectives of improving credit quality and increasing investment returns.  In connection with our portfolio management, we may engage in various collection and foreclosure activities.

If we acquire real estate pursuant to a foreclosure or bankruptcy proceeding, the assets will initially be included on the consolidated balance sheet at the lower of cost or estimated fair value.

Leased Property

Our leased real estate properties, represented by 418 SNFs, 16 assisted living facilities (“ALFs”) and 11 specialty facilities at March 31, 2013, are leased under provisions of single or master leases with initial terms typically ranging from 5 to 15 years, plus renewal options.  Substantially all of our leases contain provisions for specified annual increases over the rents of the prior year and are generally computed in one of three methods depending on specific provisions of each lease as follows: (i) a specific annual percentage increase over the prior year’s rent, generally 2.5%; (ii) an increase based on the change in pre-determined formulas from year to year (i.e., such as increases in the Consumer Price Index (“CPI”)); or (iii) specific dollar increases over prior years.  Under the terms of the leases, the lessee is responsible for all maintenance, repairs, taxes and insurance on the leased properties.

7

The facilities acquired in 2012 are included in our results of operations from the date of acquisition.  The following unaudited pro forma results of operations reflect the impact of the transactions as if they occurred on January 1, 2012.  In the opinion of management, all significant necessary adjustments to reflect the effect of the acquisitions have been made.  The following pro forma information is not indicative of future operations.

	Pro Forma
	Three Months Ended
	March 31,
	2013		2012
	(in thousands, except per share amounts, unaudited)
Revenues	$	101,761	$	98,021
Net income available to common stockholders		38,120		31,690
Earnings per share – diluted:
Net income available to common stockholders – as reported	$	0.34	$	0.25
Net income available to common stockholders – pro forma		0.34		0.30

Assets Held for Sale

At March 31, 2013, we had two SNFs and one parcel of land classified as held-for-sale with an aggregate net book value of approximately $1.0 million.

Mortgage Notes Receivables

Our mortgage notes receivables relate to 13 fixed-rate mortgages on 32 long-term care facilities and one construction mortgage on one facility currently under construction.  The mortgage notes are secured by first mortgage liens on the borrowers’ underlying real estate and personal property.  The mortgage notes receivable relate to facilities located in five (5) states, which are operated by five (5) independent healthcare operating companies.  We monitor compliance with mortgages and when necessary have initiated collection, foreclosure and other proceedings with respect to certain outstanding loans.  As of March 31, 2013, none of our mortgages were in default or in foreclosure proceedings.  Where appropriate, the mortgage properties are generally cross-collateralized with the master lease agreement.

Mortgage interest income is recognized as earned over the terms of the related mortgage notes, using the effective yield method.  Allowances are provided against earned revenues from mortgage interest when collection of amounts due becomes questionable or when negotiations for restructurings of troubled operators lead to lower expectations regarding ultimate collection.  When collection is uncertain, mortgage interest income on impaired mortgage loans is recognized as received after taking into account application of security deposits.

8

NOTE 3 – CONCENTRATION OF RISK

As of March 31, 2013, our portfolio of real estate investments consisted of 479 healthcare facilities, located in 34 states and operated by 46 third-party operators.  Our gross investment in these facilities, net of impairments and before reserve for uncollectible loans, totaled approximately $3.3 billion at March 31, 2013, with approximately 99% of our real estate investments related to long-term care facilities.  This portfolio is made up of 418 SNFs, 16 ALFs, 11 specialty facilities, fixed rate mortgages on 32 SNFs, and two SNFs that are held-for-sale.  At March 31, 2013, we also held miscellaneous investments of approximately $48.5 million, consisting primarily of secured loans to third-party operators of our facilities.

At March 31, 2013, we had investments with two operators and/or managers that exceeded 10% of our total investment: (i) Genesis Healthcare (“Genesis”) (11%), and (ii) CommuniCare Health Services, Inc. (“CommuniCare”) (10%).  The three states in which we had our highest concentration of investments were Florida (18%), Ohio (11%) and Indiana (10%) at March 31, 2013.

For the three-month period ended March 31, 2013, our revenues from operations totaled $101.8 million, of which approximately $13.8 million were from Genesis (14%) and $11.1 million from CommuniCare (11%).  No other operator generated more than 10% of our revenues from operations for the three-month period ended March 31, 2013.

NOTE 4 – DIVIDENDS

Common Dividends

On April 16, 2013, the Board of Directors declared a common stock dividend of $0.46 per share, increasing the quarterly common dividend by $0.01 per share over the prior quarter, to be paid May 15, 2013 to common stockholders of record on April 30, 2013.

On January 16, 2013, the Board of Directors declared a common stock dividend of $0.45 per share, increasing the quarterly common dividend by $0.01 per share over the prior quarter, which was paid February 15, 2013 to common stockholders of record on January 31, 2013.

NOTE 5 – TAXES

So long as we qualify as a real estate investment trust (“REIT”) under the Internal Revenue Code (the “Code”), we generally will not be subject to federal income taxes on the REIT taxable income that we distribute to stockholders, subject to certain exceptions.  On a quarterly and annual basis, we test our compliance within the REIT taxation rules to ensure that we were in compliance with the rules.

Subject to the limitation under the REIT asset test rules, we are permitted to own up to 100% of the stock of one or more taxable REIT subsidiaries (“TRSs”).  Currently, we have one TRS that is taxable as a corporation and that pays federal, state and local income tax on its net income at the applicable corporate rates.  As of March 31, 2013, the TRS had a net operating loss carry-forward of $1.1 million.  The loss carry-forward is fully reserved with a valuation allowance as of March 31, 2013.

9

NOTE 6 – STOCK-BASED COMPENSATION

The following is a summary of our stock-based compensation expense for the three- month periods ended March 31, 2013 and 2012, respectively:

	Three Months Ended March 31,
	2013		2012
	(in thousands)
Stock-based compensation expense	$	1,452	$	1,485

Stock Awards

Effective January 2011, we granted 428,503 shares of restricted stock and 496,977 performance restricted stock units (“PRSUs”) to six employees.In each of January 2012 and 2013, we granted an additional 124,244 PRSUs to six employees.

Restricted Stock Awards

The restricted stock awards vest 100% on December 31, 2013, subject to continued employment on the vesting date and subject to certain exceptions for certain qualifying terminations of employment or a change in control of the Company.  As of March 31, 2013, no shares of restricted stock have vested under these restricted stock awards.

Performance Restricted Stock Units

Effective January 1, 2011, we awarded three types of PRSUs to the six employees: (i) 124,244 annual total shareholder return (“TSR”) PRSUs for the year ended December 31, 2011 (“2011 Annual TSR PRSUs”); (ii) 279,550 multi-year absolute TSR PRSUs and (iii) 93,183 multi-year relative TSR PRSUs.  On January 1, 2012 and 2013, we awarded to the six employees 124,244 annual TSR PRSUs for the year ended December 31, 2012 and 2013 (the “2012 Annual TSR PRSUs” and the “2013 Annual TSR PRSUs”).

Annual TSR PRSUs

The number of shares earned under the annual TSR PRSUs depends generally on the level of achievement of TSR for the year.  The annual TSR PRSUs vest on December 31 of the year, subject to continued employment on the vesting date and subject to certain exceptions for certain qualifying terminations of employment or a change in control of the Company.  The 2011 Annual TSR PRSUs were forfeited because the required TSR for 2011 was not achieved.  The performance requirement for the 2012 Annual TSR PRSUs was achieved and the 124,244 shares vested and were distributed to the employees at December 31, 2012.  As of March 31, 2013, the 2013 annual TSR PRSUs have not been earned.

Multi-year Absolute TSR PRSUs

The number of shares earned under the multi-year absolute TSR PRSUs depends generally on the level of achievement of TSR for the three-years ending December 31, 2013.  The multi-year absolute TSR PRSUs vest 25% on the last day of each calendar quarter in 2014, subject to continued employment on the vesting date and subject to certain exceptions for certain qualifying terminations of employment or a change in control of the Company.

10

Multi-year Relative TSR PRSUs

The number of shares earned under the multi-year relative TSR PRSUs depends generally on the level of achievement of TSR relative to other real estate investment trusts in the MSCI U.S. REIT Index for the three-years ending December 31, 2013.  The multi-year relative TSR PRSUs vest 25% on the last day of each calendar quarter in 2014, subject to continued employment on the vesting date and subject to certain exceptions for certain qualifying terminations of employment or a change in control of the Company.

The PRSU awards have varying degrees of performance requirements to achieve vesting, and each PRSU award represents the right to a variable number of shares of common stock and related dividend equivalents based on dividends paid to stockholders during the applicable performance period.

As of March 31, 2013, none of the PRSUs are vested or earned.

The following table summarizes our total unrecognized compensation cost as of March 31, 2013 associated with outstanding restricted stock and PRSU awards to employees:

	Shares/ Units		Grant Date Average Fair Value Per Unit/ Share		Total Compensation Cost (in millions)		Weighted Average Period of Expense Recognition (in months)		Unrecognized Compensation Cost (in millions)
Restricted stock		428,503	$	22.44	$	9.6		36	$	2.4
2013 Annual PRSUs		124,244	$	8.92		1.1		12		0.8
Multi-year absolute TSR PRSUs		279,550	$	11.06		3.1		44		1.1
Multi-year relative TSR PRSUs		93,183	$	12.26		1.1		44		0.4
Total		925,480	$	14.93	$	14.9			$	4.7

We used a Monte Carlo model to estimate the fair value for PRSUs granted to the employees.

Director Restricted Stock Grants

As of March 31, 2013, we had 21,957 shares of restricted stock outstanding to directors.  The directors’ restricted shares are scheduled to vest over the next three years.  As of March 31, 2013, the unrecognized compensation cost associated with outstanding director restricted stock grants is approximately $0.3 million.

11

NOTE 7 – FINANCING ACTIVITIES AND BORROWING ARRANGEMENTS

Secured and Unsecured Borrowings

The following is a summary of our long-term borrowings:

	Maturity	Current Rate			March 31, 2013		December 31, 2012
					(in thousands)
Secured borrowings:
HUD Berkadia mortgages assumed June 2010 (1)	2036 - 2040		6.61	%	$	62,515	$	62,921
HUD Capital Funding mortgages assumed June 2010 (1)	2040 - 2045		4.85	%		130,332		130,887
HUD mortgages assumed October 2011 (1)	2036 - 2040		4.87	%		31,782		31,991
HUD mortgages assumed December 2011(1)	2044		3.06	%		59,355		58,884
HUD mortgages assumed December 2012(1)	2031 - 2045		5.50	%		81,444		81,855
Total secured borrowings						365,428		366,538
Unsecured borrowings:
Revolving line of credit	2016		-		$	—	$	158,000
Term Loan	2017		1.95	%		200,000		100,000
						200,000		258,000
2020 Notes	2020		7.50	%		200,000		200,000
2022 Notes	2022		6.75	%		575,000		575,000
2024 Notes	2024		5.875	%		400,000		400,000
Subordinated debt	2021		9.00	%		21,008		21,049
						1,196,008		1,196,049
Premium - net						4,258		4,345
Total unsecured borrowings						1,400,266		1,458,394
Totals – net					$	1,765,694	$	1,824,932

(1) Reflects the weighted average annual interest rate on the mortgages.

Certain of our other secured and unsecured borrowings are subject to customary affirmative and negative covenants, including financial covenants.  As of December 31, 2012 and March 31, 2013, we were in compliance with all affirmative and negative covenants, including financial covenants, for our secured and unsecured borrowings.

Bank Credit Agreements

We have a $700 million unsecured credit facility that we entered into on December 6, 2012, comprised of a $500 million unsecured revolving credit facility  (the “2012 Revolving Credit Facility”) and a $200 million unsecured, deferred draw term loan facility (the “2012 Term Loan Facility” and, together with the 2012 Revolving Credit Facility, collectively, the “2012 Credit Facilities”).

The 2012 Credit Facilities include an “accordion feature” that permits us to expand its borrowing capacity by a combined $300 million, to a total of $1 billion.

At March 31, 2013, we had no borrowings and no letters of credit outstanding under the 2012 Revolving Credit Facility.  The 2012 Revolving Credit Facility matures on December 6, 2016, with an option by us to extend the maturity one additional year.  The 2012 Revolving Credit Facility is priced at LIBOR plus an applicable percentage (beginning at 150 basis points, with a range of 100 to 190 basis points) based on our ratings from Standard & Poor’s, Moody’s and/or Fitch Ratings, plus a facility fee based on the same ratings (initially 30 basis points, with a range of 15 to 45 basis points).

At March 31, 2013, the full $200 million was outstanding under the 2012 Term Loan Facility.  The 2012 Term Loan Facility is also priced at LIBOR plus an applicable percentage (beginning at 175 basis points, with a range of 110 to 230 basis points) based our ratings from Standard & Poor’s, Moody’s and/or Fitch Ratings.  The 2012 Term Loan Facility matures on December 6, 2017.

12

HUD Mortgage Debt Refinancing

On March 26, 2013, we refinanced existing HUD mortgage debt on 12 properties in Arkansas for approximately $59.4 million including closing costs that were added to the outstanding balance.  The annual interest rate for the refinanced debt decreased from 5.55% to approximately 3.06%, with the term of the refinanced mortgages remaining unchanged.  For the three months ended March 31, 2013, we paid off a total of $58.9 million, including routine principal payments on the 12 Arkansas mortgage debts.

$250 Million Equity Shelf Program

On March 18, 2013, we entered into separate Equity Distribution Agreements (collectively, the “2013 Agreements”) to sell shares of our common stock having an aggregate gross sales price of up to $250 million (the “2013 ESP”) with several financial institutions, each as a sales agent and/or principal (collectively, the “Managers”).  Under the terms of the 2013 Agreements, we may sell shares of our common stock, from time to time, through or to the Managers having an aggregate gross sales price of up to $250 million.  Sales of the shares will be made by means of ordinary brokers’ transactions on the New York Stock Exchange at market prices, or as otherwise agreed with the applicable Manager.  We will pay each Manager compensation for sales of the shares equal to 2% of the gross sales price per share of shares sold through such Manager under the applicable 2013 Agreement.  We are not obligated to sell and the Managers are not obligated to buy or sell any shares under the 2013 Agreements.  No assurance can be given that we will sell any shares under the 2013 Agreements, or, if we do, as to the price or amount of shares that we sell, or the dates when such sales will take place.

For the three months ended March 31, 2013, we sold 1.5 million shares under the 2013 ESP, at an average price of $29.41 per share, generating gross proceeds of approximately $42.8 million, before $0.9 million of commissions.  Of the 1.5 million shares that we sold during the quarter, 0.6 million shares, representing gross proceeds of approximately $18.0 million had a settlement date in April 2013. We included net proceeds of $17.6 million as a receivable in other assets at March 31, 2013 with a corresponding increase in equity.

Termination of $245 Million Equity Shelf Program

On March 18, 2013, we terminated our $245 million Equity Shelf Program (the “2012 ESP”) that we entered into with several financial institutions on June 19, 2012.  For the three months ended March 31, 2013, we issued approximately 1.0 million shares under the 2012 ESP at an average price of $28.29 per share, generating gross proceeds of approximately $27.8 million, before $0.6 million commissions.

Since inception of the 2012 ESP, we have sold a total of 3.6 million shares of common stock generating total gross proceeds of $91.4 million under the program, before $1.9 million of commissions.  As a result of the termination of the 2012 ESP, no additional shares were issued under the 2012 ESP.

Dividend Reinvestment and Common Stock Purchase Plan

For the three-month period ended March 31, 2013, approximately 1.3 million shares of our common stock at an average price of $27.63 per share were issued through our Dividend Reinvestment and Common Stock Purchase Program for net proceeds of approximately $36.3 million.

13

NOTE 8 – FINANCIAL INSTRUMENTS

At March 31, 2013 and December 31, 2012, the carrying amounts and fair values of our financial instruments were as follows:

	March 31, 2013				December 31, 2012
	Carrying Amount		Fair Value		Carrying Amount		Fair Value
Assets:	(in thousands)
Cash and cash equivalents	$	25,611	$	25,611	$	1,711	$	1,711
Restricted cash		34,377		34,377		36,660		36,660
Mortgage notes receivable – net		240,551		238,145		238,621		235,705
Other investments – net		48,537		45,427		47,339		44,077
Totals	$	349,076	$	343,560	$	324,331	$	318,153
Liabilities:
Revolving line of credit	$	—	$	—	$	158,000	$	158,000
Term loan		200,000		200,000		100,000		100,000
7.50% Notes due 2020 – net		197,632		253,145		197,546		252,363
6.75% Notes due 2022 – net		581,626		732,702		581,799		724,240
5.875% Notes due 2024 – net		400,000		437,027		400,000		441,761
HUD debt		365,428		412,821		366,538		433,803
Subordinated debt		21,008		27,771		21,049		27,896
Totals	$	1,765,694	$	2,063,466	$	1,824,932	$	2,138,063

Fair value estimates are subjective in nature and are dependent on a number of important assumptions, including estimates of future cash flows, risks, discount rates and relevant comparable market information associated with each financial instrument (see Note 2 – Summary of Significant Accounting Policies in our 2012 Annual Report on Form 10-K).  The use of different market assumptions and estimation methodologies may have a material effect on the reported estimated fair value amounts.

The following methods and assumptions were used in estimating fair value disclosures for financial instruments.

● Cash and cash equivalents and restricted cash:  The carrying amount of cash and cash equivalents and restricted cash reported in the balance sheet approximates fair value because of the short maturity of these instruments (i.e., less than 90 days).

● Mortgage notes receivable:  The fair values of the mortgage notes receivables are estimated using a discounted cash flow analysis, using interest rates being offered for similar loans to borrowers with similar credit ratings (Level 3).

● Other investments:  Other investments are primarily comprised of: (i) notes receivable and (ii) an investment in redeemable non-convertible preferred security of an unconsolidated business accounted for using the cost method of accounting.  The fair values of notes receivable are estimated using a discounted cash flow analysis, using interest rates being offered for similar loans to borrowers with similar credit ratings (Level 3).  The fair value of the investment in the unconsolidated business is estimated using quoted market value and considers the terms of the underlying arrangement (Level 3).

● Revolving line of credit:  The fair value of our borrowings under variable rate agreements are estimated using an expected present value technique based on expected cash flows discounted using the current market rates (Level 2).

● Senior notes and other long-term borrowings:  The fair value of our borrowings under fixed rate agreements are estimated based on open market trading activity provided by a third party (Level 2).

14

NOTE 9 – LITIGATION

We are subject to various legal proceedings, claims and other actions arising out of the normal course of business. While any legal proceeding or claim has an element of uncertainty, management believes that the outcome of each lawsuit, claim or legal proceeding that is pending or threatened, or all of them combined, will not have a material adverse effect on our consolidated financial position or results of operations.

NOTE 10 – EARNINGS PER SHARE

The computation of basic earnings per share (“EPS”) is computed by dividing net income available to common stockholders by the weighted-average number of shares of common stock outstanding during the relevant period.  Diluted EPS is computed using the treasury stock method, which is net income available to common stockholders divided by the total weighted-average number of common outstanding shares plus the effect of dilutive common equivalent shares during the respective period.  Dilutive common shares reflect the assumed issuance of additional common shares pursuant to certain of our share-based compensation plans, including stock options, restricted stock and performance restricted stock units.

The following tables set forth the computation of basic and diluted earnings per share:

	Three Months Ended March 31,
	2013		2012
	(in thousands, except per share amounts)
Numerator:
Net income	$	38,120	$	26,084
Numerator for net income available to common per share - basic and diluted	$	38,120	$	26,084
Denominator:
Denominator for basic earnings per share		112,782		103,754
Effect of dilutive securities:
Restricted stock		714		241
Deferred stock		26		17
Denominator for diluted earnings per share		113,522		104,012
Earnings per share – basic:
Net income – basic	$	0.34	$	0.25
Earnings per share – diluted:
Net income – diluted	$	0.34	$	0.25

15

NOTE 11 – CONSOLIDATING FINANCIAL STATEMENTS
 

As of March 31, 2013, we had outstanding (i) $200 million 7.5% Senior Notes due 2020, (ii) $575 million 6.75% Senior Notes due 2022 and (iii) $400 million 5.875% Senior Notes due 2024, which we collectively refer to as the Senior Notes.  The Senior Notes are fully and unconditionally guaranteed, jointly and severally, by each of our subsidiaries that guarantee other indebtedness of Omega or any of the subsidiary guarantors.  Any subsidiary that we properly designate as an “unrestricted subsidiary” under the indentures governing the Senior Notes will not provide guarantees of the Senior Notes.  As of and prior to March 31, 2010, the non-subsidiary guarantors were minor and insignificant.  On June 29, 2010, we designated as “unrestricted subsidiaries” the 39 subsidiaries we acquired from CapitalSource subject to HUD indebtedness.  During the fourth quarter of 2011, we designated as “unrestricted subsidiaries” 20 subsidiaries we acquired subject to HUD indebtedness, of which five subsidiaries were removed in July 2012 due to the retirement of the HUD related mortgages.  During the fourth quarter of 2012, we designated as “unrestricted subsidiaries” eight subsidiaries we acquired subject to HUD indebtedness.
 

For the three months ended March 31, 2013 and 2012, the operating cash flow of the non-guarantor subsidiaries approximated net income of the non-guarantor subsidiaries, adjusted for depreciation and amortization expense.  On March 26, 2013, the non-guarantor subsidiaries refinanced existing HUD mortgage debt on 12 properties in Arkansas for approximately $59.4 million. The refinanced amount included $58.9 million related to retiring the old HUD debt and $0.5 million of closing costs that were added to the new (refinanced) HUD debt.  In addition, the non-guarantor subsidiaries also made $1.1 million of routine principal payments during the three months ended March 31, 2013.  For the three-month period ended March 31, 2013, the non-guarantor subsidiaries have not engaged in investing or financing activities other than the refinancing activity and routine principal payments.  For the three-month period ended March 31, 2012, the non-guarantor subsidiaries have not engaged in investing or financing activities other than the principal payment of $1.0 million for the HUD mortgages on the facilities owned by the non-guarantor subsidiaries.  All of the subsidiary and non-subsidiary guarantors of our outstanding senior notes are 100% owned by Omega.
 

The following summarized condensed consolidating financial information segregates the financial information of the non-guarantor subsidiaries from the financial information of Omega Healthcare Investors, Inc. and the subsidiary guarantors under the Senior Notes.  The results and financial position of acquired entities are included from the dates of their respective acquisitions.

16

OMEGA HEALTHCARE INVESTORS, INC.

CONSOLIDATING BALANCE SHEETS

Unaudited

(in thousands, except per share amounts)
 

	March 31, 2013
	Issuer & Subsidiary Guarantors			Non-Guarantor Subsidiaries			Elimination Company			Consolidated
Real estate properties
Land and buildings	$	2,475,194		$	571,611		$	—		$	3,046,805
Less accumulated depreciation		(560,768	)		(51,534	)		—			(612,302	)
Real estate properties – net		1,914,426			520,077			—			2,434,503
Mortgage notes receivable – net		240,551			—			—			240,551
		2,154,977			520,077			—			2,675,054
Other investments – net		48,537			—			—			48,537
		2,203,514			520,077			—			2,723,591
Assets held for sale – net		1,020			—			—			1,020
Total investments		2,204,534			520,077			—			2,724,611
Cash and cash equivalents		25,611			—			—			25,611
Restricted cash		6,675			27,702			—			34,377
Accounts receivable – net		122,435			7,823			—			130,258
Investment in affiliates		159,319			—			(159,319	)		—
Other assets		54,004			35,780			—			89,784
Total assets	$	2,572,578		$	591,382		$	(159,319	)	$	3,004,641
LIABILITIES AND STOCKHOLDERS’ EQUITY
Revolving line of credit	$	200,000		$	—		$	—		$	200,000
Secured borrowings		—			365,428			—			365,428
Unsecured borrowings – net		1,179,258			21,008			—			1,200,266
Accrued expenses and other liabilities		87,566			45,627			—			133,193
Intercompany payable		—			134,788			(134,788	)		—
Total liabilities		1,466,824			566,851		$	(134,788	)	$	1,898,887
Stockholders’ equity:
Common stock		11,615			—			—			11,615
Common stock – additional paid-in-capital		1,771,374			—			—			1,771,374
Cumulative net earnings		792,248			24,531			(24,531	)		792,248
Cumulative dividends paid		(1,469,483	)		—			—			(1,469,483	)
Total stockholders’ equity		1,105,754			24,531		$	(24,531	)		1,105,754
Total liabilities and stockholders’ equity	$	2,572,578		$	591,382		$	(159,319	)		3,004,641

17

OMEGA HEALTHCARE INVESTORS, INC.

CONSOLIDATING BALANCE SHEETS

 (in thousands, except per share amounts)
 

	December 31, 2012
	Issuer & Subsidiary Guarantors			Non – Guarantor Subsidiaries			Elimination Company			Consolidated
ASSETS
Real estate properties
Land and buildings	$	2,466,866		$	571,687		$	—		$	3,038,553
Less accumulated depreciation		(535,223	)		(45,150	)		—			(580,373	)
Real estate properties – net		1,931,643			526,537			—			2,458,180
Mortgage notes receivable – net		238,621			—			—			238,621
		2,170,264			526,537			—			2,696,801
Other investments – net		47,339			—			—			47,339
		2,217,603			526,537			—			2,744,140
Assets held for sale – net		1,020			—			—			1,020
Total investments		2,218,623			526,537			—			2,745,160
Cash and cash equivalents		1,711			—			—			1,711
Restricted cash		7,078			29,582			—			36,660
Accounts receivable – net		118,473			6,707			—			125,180
Investment in affiliates		163,610			—			(163,610	)		—
Other assets		38,224			35,070			—			73,294
Total assets	$	2,547,719		$	597,896			(163,610	)	$	2,982,005
LIABILITIES AND STOCKHOLDERS’ EQUITY
Revolving line of credit	$	258,000		$	—		$	—		$	258,000
Secured borrowings		—			366,538			—			366,538
Unsecured borrowings – net		1,179,345			21,049			—			1,200,394
Accrued expenses and other liabilities		99,045			46,699			—			145,744
Intercompany payable		—			143,158			(143,158	)		—
Total liabilities		1,536,390			577,444			(143,158	)		1,970,676
Stockholders’ equity:
Common stock		11,239			—			—			11,239
Common stock – additional paid-in-capital		1,664,855			—			—			1,664,855
Cumulative net earnings		754,128			20,452			(20,452	)		754,128
Cumulative dividends paid		(1,418,893	)		—			—			(1,418,893	)
Total stockholders’ equity		1,011,329			20,452			(20,452	)		1,011,329
Total liabilities and stockholders’ equity	$	2,547,719		$	597,896		$	(163,610	)	$	2,982,005

18

OMEGA HEALTHCARE INVESTORS, INC.

CONSOLIDATING STATEMENTS OF OPERATIONS

Unaudited

(in thousands, except per share amounts)

	Three Months Ended March 31, 2013
	Issuer & Subsidiary Guarantors			Non – Guarantor Subsidiaries			Elimination Company			Consolidated
Revenue
Rental income	$	77,641		$	15,468		$	-		$	93,109
Mortgage interest income		7,346			-			-			7,346
Other investment income – net		1,306			-			-			1,306
Total operating revenues		86,293			15,468			-			101,761
Expenses
Depreciation and amortization		25,575			6,384			-			31,959
General and administrative		5,082			115			-			5,197
Acquisition costs		134			-			-			134
Total operating expenses		30,791			6,499			-			37,290
Income before other income and expense		55,502			8,969			-			64,471
Other income (expense):
Interest income		(5	)		8			-			3
Interest expense		(20,774	)		(4,898	)		-			(25,672	)
Interest – amortization of deferred financing costs		(682	)		-			-			(682	)
Equity in earnings		4,079			-			(4,079	)		-
Total other expense		(17,382	)		(4,890	)		(4,079	)		(26,351	)
Net income available to common stockholders	$	38,120		$	4,079		$	(4,079	)	$	38,120

19

OMEGA HEALTHCARE INVESTORS, INC.

CONSOLIDATING STATEMENTS OF OPERATIONS

Unaudited

(in thousands, except per share amounts)

	Three Months Ended March 31, 2012
	Issuer & Subsidiary Guarantors			Non – Guarantor Subsidiaries			Elimination Company			Consolidated
Revenue
Rental income	$	63,964		$	12,011		$	-		$	75,975
Mortgage interest income		7,336			-			-			7,336
Other investment income – net		1,130			-			-			1,130
Miscellaneous		74			-			-			74
Total operating revenues		72,504			12,011			-			84,515
Expenses
Depreciation and amortization		21,899			5,248			-			27,147
General and administrative		5,414			112			-			5,526
Acquisition costs		105			-			-			105
Impairment loss on real estate properties		272			-			-			272
Total operating expenses		27,690			5,360			-			33,050
Income before other income and expense		44,814			6,651			-			51,465
Other income (expense):
Interest income		-			7			-			7
Interest expense		(19,107	)		(3,860	)		-			(22,967	)
Interest – amortization of deferred financing costs		(629	)		-			-			(629	)
Interest – refinancing costs		(7,108	)		-			-			(7,108	)
Equity in earnings		2,798			-			(2,798	)		-
Total other expense		(24,046	)		(3,853	)		(2,798	)		(30,697	)
Income before gain on assets sold		20,768			2,798			(2,798	)		20,768
Gain on assets sold – net		5,316			-			-			5,316
Net income available to common stockholders	$	26,084		$	2,798		$	(2,798	)	$	26,084

20

NOTE 12 – SUBSEQUENT EVENTS

$25 Million Mezzanine Loan

In May 2013, we invested in a $24.7 million mezzanine loan with a third party.  The loan bears interest at 12% per annum and matures in December 2017.

HUD Loans Payoff

During the second quarter of 2013, we notified Berkadia of our intent to retire the HUD Berkadia mortgages.  We anticipate using approximately $51.1 million in funds borrowed from our 2012 Credit Facility to repay the contractual portion of the HUD Berkadia Mortgages.  We also anticipate accelerating the amortization of the $11.4 million of premium associated with the HUD Berkadia mortgages.

21

Item 2 – Management’s Discussion and Analysis of Financial Condition and Results of Operations

Forward-looking Statements, Reimbursement Issues and Other Factors Affecting Future Results

The following discussion should be read in conjunction with the financial statements and notes thereto appearing elsewhere in this document, including statements regarding potential future changes in reimbursement.  This document contains forward-looking statements within the meaning of the federal securities laws.  These statements relate to our expectations, beliefs, intentions, plans, objectives, goals, strategies, future events, performance and underlying assumptions and other statements other than statements of historical facts.  In some cases, you can identify forward-looking statements by the use of forward-looking terminology including, but not limited to, terms such as “may,” “will,” “anticipates,” “expects,” “believes,” “intends,” “should” or comparable terms or the negative thereof.  These statements are based on information available on the date of this filing and only speak as to the date hereof and no obligation to update such forward-looking statements should be assumed.  Our actual results may differ materially from those reflected in the forward-looking statements contained herein as a result of a variety of factors, including, among other things:

(i) those items discussed under “Risk Factors” in Item 1A to our annual report on Form 10-K for the year ended December 31, 2012, and in Part II, Item 1A of this report;

(ii) uncertainties relating to the business operations of the operators of our assets, including those relating to reimbursement by third-party payors, regulatory matters and occupancy levels;

(iii) the ability of any operators in bankruptcy to reject unexpired lease obligations, modify the terms of our mortgages and impede our ability to collect unpaid rent or interest during the process of a bankruptcy proceeding and retain security deposits for the debtors’ obligations;

(iv) our ability to sell closed or foreclosed assets on a timely basis and on terms that allow us to realize the carrying value of these assets;

(v) our ability to negotiate appropriate modifications to the terms of our credit facilities;

(vi) our ability to manage, re-lease or sell any owned and operated facilities;

(vii) the availability and cost of capital;

(viii) changes in our credit ratings and the ratings of our debt securities;

(ix) competition in the financing of healthcare facilities;

(x) regulatory and other changes in the healthcare sector;

(xi) the effect of economic and market conditions generally and, particularly, in the healthcare industry;

(xii) changes in the financial position of our operators;

(xiii) changes in interest rates;

(xiv) the amount and yield of any additional investments;

(xv) changes in tax laws and regulations affecting real estate investment trusts; and

(xvi) our ability to maintain our status as a real estate investment trust.

Overview

We have one reportable segment consisting of investments in healthcare related real estate properties.  Our core business is to provide financing and capital to the long-term healthcare industry with a particular focus on skilled nursing facilities (“SNFs”) located in the United States.  Our core portfolio consists of long-term leases and mortgage agreements.  All of our leases are “triple-net” leases, which require the tenants to pay all property-related expenses.  Our mortgage revenue derives from fixed-rate mortgage loans, which are secured by first mortgage liens on the underlying real estate and personal property of the mortgagor.

Our portfolio of investments at March 31, 2013, consisted of 479 healthcare facilities (including two facilities classified as held for sale), located in 34 states and operated by 46 third-party operators.  Our gross investment in these facilities totaled approximately $3.3 billion at March 31, 2013, with 99% of our real estate investments related to long-term healthcare facilities.  This portfolio is made up of (i) 418 SNFs, (ii) 16 assisted living facilities (“ALFs”), (iii) 11 specialty facilities, (iv) fixed rate mortgages on 32 SNFs and (v) two SNFs that are held for sale.  At March 31, 2013, we also held other investments of approximately $48.5 million, consisting primarily of secured loans to third-party operators of our facilities.

22

Our consolidated financial statements include the accounts of (i) Omega, (ii) all direct and indirect wholly owned subsidiaries of Omega and (iii) TC Healthcare, a variable interest entity (“VIE”) that we consolidate as the primary beneficiary.  All inter-company accounts and transactions have been eliminated in consolidation of the financial statements.

Taxation

We have elected to be taxed as a Real Estate Investment Trust (“REIT”), under Sections 856 through 860 of the Internal Revenue Code (the “Code”), beginning with our taxable year ended December 31, 1992.  We believe that we have been organized and operated in such a manner as to qualify for taxation as a REIT. We intend to continue to operate in a manner that will maintain our qualification as a REIT, but no assurance can be given that we have operated or will be able to continue to operate in a manner so as to qualify or remain qualified as a REIT.  Under the Code, we generally are not subject to federal income tax on taxable income distributed to stockholders if certain distribution, income, asset and stockholder tests are met, including a requirement that we must generally distribute at least 90% of our annual taxable income, excluding any net capital gain, to stockholders.  If we fail to qualify as a REIT in any taxable year, we may be subject to federal income taxes on our taxable income for that year and for the four years following the year during which qualification is lost, unless the Internal Revenue Service grants us relief under certain statutory provisions. Such an event could materially adversely affect our net income and net cash available for distribution to our stockholders.  For further information, see “Taxation” in Item 1 of our annual report on Form 10-K for the year ended December 31, 2012.

Government Regulation and Reimbursement

The following is a description of certain of the laws and regulations and reimbursement policies and programs affecting our business and the businesses conducted by our operators.  The following description should be read in conjunction with the risk factors described under “Item 1A – Risk Factors.”

Healthcare Reform.  The Patient Protection and Affordable Care Act and accompanying Healthcare and Education Affordability and Reconciliation Act of 2010 (the “Healthcare Reform Law”) were signed into law in March 2010. This legislation represents the most comprehensive change to healthcare benefits since the inception of the Medicare program in 1965 and will affect reimbursement for governmental programs, private insurance and employee welfare benefit plans in various ways.  Significant rule making and regulation promulgated under the Healthcare Reform Law has already occurred, and we expect additional rules, regulations and interpretation that may materially affect the operations of our operators.

On June 28, 2012, the U.S. Supreme Court upheld all of the Healthcare Reform Law except for the requirement that states expand Medicaid beginning in 2014. However, the Healthcare Reform Law and the implementation thereof continue to receive challenge and scrutiny from Congress, state attorneys general and legislators, and private individuals and organizations.  For example, several congressional bills and budget proposals have sought to repeal or change certain provisions of the law.

In addition, certain measures recently taken under the authority of, or in connection with, the Healthcare Reform Law may lead to additional modification and/or clarification in the future, including the following:

●         On January 3, 2013, a new federal Commission on Long-Term Care was established and tasked with developing a plan for the establishment, implementation and financing of a high-quality system to provide long-term care services.

23

●         The Healthcare Reform Law requires private health insurers that sell policies to individuals and small businesses to provide, starting in 2014, a set of “essential health benefits” in ten categories, including prescription drugs, rehabilitative and habilitative services, and chronic disease management.  As required under the law, states define the essential health benefits. States are now submitting their essential health benefit packages to the Department of Health and Human Services (HHS).  How these benefits are established will affect payments for long term care facilities.

●         The Healthcare Reform Law requires SNFs to implement a compliance and ethics program by March 23, 2013 that is effective in preventing and detecting criminal, civil and administrative violations and in promoting quality of care.  HHS has not yet issued the proposed regulations to implement this law that were due in March 2012.  It is unclear whether this provision of the law will be enforced until the regulations are issued.

Given the recent and potential for future challenges to the Healthcare Reform Law, in addition to the complexity of the law and the substantial requirements for regulation thereunder, the impact of the Healthcare Reform Law on our operators or their ability to meet their obligations to us is uncertain.  The Healthcare Reform Law could result in decreases in payments to our operators or otherwise adversely affect the financial condition of our operators, thereby negatively impacting our financial condition.  The efforts of our operators to modify their operations to lessen the impact of any increased costs or other adverse effects resulting from changes in governmental programs, private insurance and/or employee welfare benefit plans may not be successful.  The impact of the Healthcare Reform Law on each of our operators will vary depending on payor mix, resident conditions and a variety of other factors.  In addition to the provisions relating to reimbursement, other provisions of the Healthcare Reform Law may impact our operators as employers (e.g., requirements related to providing health insurance for employees). We anticipate that many of the provisions in the Healthcare Reform Law may be subject to further clarification and modification during the rule making process.

Reimbursement. A significant portion of our operators’ revenue is derived from governmentally-funded reimbursement programs, primarily Medicare and Medicaid.  According to the Alliance for Quality Nursing Home Care, as of January 2013, approximately 70% of SNF residents depend upon Medicare and/or Medicaid funding for care. The federal government and many state governments are currently focusing on reducing expenditures under Medicare and Medicaid programs, resulting in significant cost-cutting at both the federal and state levels.   These cost-cutting measures, together with the implementation of changes in reimbursement rates such as those described below, could result in a significant reduction of reimbursement rates to our operators under both the Medicare and Medicaid programs.

We currently believe that our operator coverage ratios are adequate and that our operators can absorb moderate reimbursement rate reductions and still meet their obligations to us.  However, significant limits on the scopes of services reimbursed and/or reductions of reimbursement rates could have a material adverse effect on our operators’ results of operations and financial condition, which could adversely affect our operators’ ability to meet their obligations to us.

We cannot predict whether Congress will take any action to change the automatic spending cuts.  Further, we cannot predict how states will react to any changes that occur at the federal level.

Medicaid.  State budgetary concerns, coupled with the implementation of rules under the Healthcare Reform Law, may result in significant changes in healthcare spending at the state level.

Many states are currently focusing on the reduction of expenditures under their state Medicaid programs, which may result in a reduction in reimbursement rates for our operators.  The need to control Medicaid expenditures may be exacerbated by the potential for increased enrollment in Medicaid due to unemployment and declines in family incomes.  Since our operators’ profit margins on Medicaid patients are generally relatively low, more than modest reductions in Medicaid reimbursement or an increase in the number of Medicaid patients could adversely affect our operators’ results of operations and financial conditions, which in turn could negatively impact us.

24

Under the Healthcare Reform Law, Medicaid coverage will be expanded to all individuals under age 65 with incomes up to 133% of the federal poverty level, beginning January 1, 2014.  The federal government will pay the entire cost for Medicaid coverage for newly eligible beneficiaries for 3 years (2014 through 2016).  In 2017, the federal share declines to 95%; in 2018, to 94%; in 2019, to 93%; and in 2020 and subsequent years, to 90%.  States may delay Medicaid expansion after 2014 but the federal payment rates will be less.  However, on June 28, 2012, the Supreme Court issued its opinion in National Federation of Independent Business v. Sebellius, which stated that states could not be required to expand Medicaid or risk losing federal funding of their existing Medicaid programs.  Currently, all but 25 states have decided to expand, although most states are involved in a variety of legislative proposals. The U.S. Department of Health and Human Services has stated that it will consider a limited number of premium assistance demonstration programs from states that want to privatize Medicaid expansion. States must provide a choice between at least two qualified health plans that offer very similar benefits as those required by the health insurance exchanges.

Medicare.  For the federal fiscal year 2013, CMS has announced that it will increase SNF payment rates by 1.8% (2.5% market basket update minus 0.7% productivity adjustment), which amounts to an estimated $670 million increase in payments to SNFs beginning October 1, 2012.  Provisions contained in the American Taxpayer Relief Act (ATRA) of 2012, known colloquially as the fiscal cliff deal, will reduce Medicare payments to SNFs by an estimated $600 million during 2012 to 2022.  It also reduces payments for multiple procedures or therapies provided on the same day, which will result in approximately $1.8 billion savings to Medicare over the next 10 years, which will impact SNFs as well.  Under the ATRA, sequestration cuts impacting domestic and defense spending became effective March 1, 2013.  Although Medicaid is exempted from the sequestration cuts, they  include a 2% cut in payments to Medicare providers and suppliers.

The Middle Class Tax Relief and Job Creation Act of 2012 was signed into law on February 22, 2012 and extended the Medicare Part B Outpatient Therapy Cap Exceptions Process through December 31, 2012.  The statutory Medicare Part B outpatient cap for occupational therapy is $1,900 for 2013, and the combined cap for physical therapy and speech therapy is also $1,900 for 2013.  These caps do not apply to therapy services covered under Medicare Part A for SNFs, although the caps apply in most other instances involving patients in SNFs or long-term care facilities who receive therapy services covered under Medicare Part B.  Congress implemented a temporary therapy cap exceptions process, which permits medically necessary therapy services to exceed the payment limits.  Expiration of the therapy cap exceptions process in the future could have a material adverse effect on our operators’ financial condition and operations, which could adversely impact their ability to meet their obligations to us.

Quality of Care Initiatives.  The CMS has implemented a number of initiatives focused on the quality of care provided by nursing homes that could affect our operators.  For instance, in December 2008, the CMS released quality ratings for all of the nursing homes that participate in Medicare or Medicaid. Facility rankings, ranging from five stars (“much above average”) to one star (“much below average”) are updated on a monthly basis.  SNFs are required to provide information for the CMS Nursing Home Compare website regarding staffing and quality measures.  Based on this data and the results of state health inspections, SNFs are then rated based on the five-star rating system.  We cannot predict what changes, if any, CMS will make to the rating system.  It is possible that this or any other ranking system could lead to future reimbursement policies that reward or penalize facilities on the basis of the reported quality of care parameters.

CMS has incorporated hospital readmissions review into the Quality Indicators Survey.  Under Medicare’s Inpatient Prospective Payment System, CMS began adjusting payments to hospitals for excessive readmissions of patients for heart attacks, heart failure, and pneumonia during fiscal years beginning on and after October 1, 2012.  Long term care facilities will be under increased scrutiny to prevent residents from being readmitted to hospitals for these conditions in particular, and have an opportunity to demonstrate their quality of care by reducing their hospital readmission rates.  It is anticipated that hospital readmissions will be a consideration in the future in the CMS five-star rating system.

25

Office of the Inspector General Activities.  The Office of Inspector General’s (OIG) Work Plan for government fiscal year 2013, which describes projects that the OIG plans to address during the fiscal year, includes a number of projects related to nursing homes.  Reviews of Medicare Part A and Part B payments and services for SNFs will focus on the following: (1) adverse events in post-acute care; (2) Medicare requirements for quality of care; (3) verification of state agency identified deficiencies’ corrections; (4) oversight of poorly performing SNFs; (5) use of atypical antipsychotic drugs; (6) hospitalizations of SNF residents; (7) questionable billing practices for Part B services; and (8) oversight of the accuracy and completeness of MDS data.  Medicaid reviews will focus on communicable diseases and MDS data.  The OIG plans to continue its efforts in addressing fraud and abuse.  While we cannot predict the results of the OIG’s activities, the projects could result in further scrutiny and/or oversight of nursing homes.

Fraud and Abuse. There are various federal and state civil and criminal laws and regulations governing a wide array of healthcare provider referrals, relationships and arrangements, including laws and regulations prohibiting fraud by healthcare providers. Many of these complex laws raise issues that have not been clearly interpreted by the relevant governmental authorities and courts.  In addition, federal and state governments are devoting increasing attention and resources to anti-fraud initiatives against healthcare providers.

The federal anti-kickback statute is a criminal statute that prohibits the knowing and willful offer, payment, solicitation or receipt of any remuneration in return for, to induce or to arrange for the referral of individuals for any item or service payable by a federal or state healthcare program. There is also a civil analogue. States also have enacted similar statutes covering Medicaid payments, and some states have broader statutes. Some enforcement efforts have targeted relationships between SNFs and ancillary providers, relationships between SNFs and referral sources for SNFs and relationships between SNFs and facilities for which the SNFs serve as referral sources. The federal self-referral law, commonly known as the “Stark Law,” is a civil statute that prohibits a physician from making referrals to an entity for “designated health services” if the physician has a financial relationship with the entity. Some of the services provided in SNFs are classified as designated health services. There are also criminal provisions that prohibit filing false claims or making false statements to receive payment or certification under Medicare and Medicaid, as well as failing to refund overpayments or improper payments. Violation of the anti-kickback statute or Stark Law may form the basis for a federal False Claims Act violation. In addition, the federal False Claims Act allows a private individual with knowledge of fraud to bring a claim on behalf of the federal government and earn a percentage of the federal government’s recovery. Because of these incentives, these so-called “whistleblower” suits have become more frequent. The violation of any of these laws or regulations by an operator may result in the imposition of fines or other penalties, including exclusion from Medicare, Medicaid and all other federal and state healthcare programs.

Privacy. Our operators are subject to various federal, state and local laws and regulations designed to protect the confidentiality and security of patient health information, including the federal Health Insurance Portability and Accountability Act of 1996, as amended, and the corresponding regulations promulgated thereunder (“HIPAA”).  On January 25, 2013, the Office for Civil Rights (OCR) issued a final rule modifying HIPAA which will require our operators to expend significant time and money to implement.  Some of the new requirements include, among other things: making business associates subject to the HIPAA Privacy and Security Rules which will require new business associate agreements; changes in determining whether a breach of unsecured protected health information occurred; new requirements for the Notice of Privacy Practices; and decreasing the time to disclose protected health information and requiring disclosures to be electronic under certain conditions.

26

Various states have similar laws and regulations that govern the maintenance and safeguarding of patient records, charts and other information generated in connection with the provision of professional medical services.  These laws and regulations require our operators to expend the requisite resources to secure protected health information, including the funding of costs associated with technology upgrades. Operators found in violation of HIPAA or any other privacy law or regulation may face large penalties. In addition, compliance with an operator’s notification requirements in the event of a breach of unsecured protected health information could cause reputational harm to an operator’s business.

Licensing and Certification. Our operators and facilities are subject to various federal, state and local licensing and certification laws and regulations, including laws and regulations under Medicare and Medicaid requiring operators of SNFs and ALFs to comply with extensive standards governing operations. Governmental agencies administering these laws and regulations regularly inspect our operators’ facilities and investigate complaints. Our operators and their managers receive notices of observed violations and deficiencies from time to time, and sanctions have been imposed from time to time on facilities operated by them.

Other Laws and Regulations.  Additional federal, state and local laws and regulations affect how our operators conduct their operations, including laws and regulations protecting consumers against deceptive practices and otherwise generally affecting our operators’ management of their property and equipment and the conduct of their operations (including laws and regulations involving fire, health and safety; quality of services, including care and food service; residents’ rights, including abuse and neglect laws; and the health standards set by the federal Occupational Safety and Health Administration).

General and Professional Liability.  Although arbitration agreements have been effective in limiting general and professional liabilities for long term care providers, there have been national efforts to outlaw the use of pre-dispute arbitration agreements in long term care settings.  At least one state is allowing residents to sue a SNF for failing to comply with staffing quality measures.  All of these factors have a potential impact on liability costs of our operators, which could adversely affect our operators’ ability to meet their obligations to us.

Critical Accounting Policies and Estimates

Our financial statements are prepared in accordance with generally accepted accounting principles in the United States of America (“GAAP”), and a summary of our significant accounting policies is included in Note 2 – Summary of Significant Accounting Policies to our Annual Report on Form 10-K for the year ended December 31, 2012.  Our preparation of the financial statements requires us to make estimates and assumptions about future events that affect the amounts reported in our financial statements and accompanying footnotes.  Future events and their effects cannot be determined with absolute certainty.  Therefore, the determination of estimates requires the exercise of judgment.  Actual results inevitably will differ from those estimates, and such difference may be material to the consolidated financial statements.  We have described our most critical accounting policies in our 2012 Annual Report on Form 10-K in Item 7, Management’s Discussion and Analysis of Financial Condition and Results of Operations.

Results of Operations

The following is our discussion of the consolidated results of operations, financial position and liquidity and capital resources, which should be read in conjunction with our unaudited consolidated financial statements and accompanying notes.

Three Months Ended March 31, 2013 and 2012

Operating Revenues

Our operating revenues for the three months ended March 31, 2013, totaled $101.8 million, an increase of $17.2 million over the same period in 2012.  The $17.2 million increase was primarily the result of additional rental income associated with new acquisitions made throughout 2012.

27

Operating Expenses

Operating expenses for the three months ended March 31, 2013, totaled $37.3 million, an increase of approximately $4.2 million over the same period in 2012.  The increase was primarily due to an increase of $4.8 million of depreciation and amortization associated with new acquisitions made throughout 2012, offset by (i) a decrease of $0.3 million in general and administrative expense and (ii) $0.3 million impairment charge for two held-for-sale facilities that were sold in 2012.

Other Income (Expense)

For the three months ended March 31, 2013, total other expenses were $26.4 million, a decrease of approximately $4.3 million over the same period in 2012.  The decrease was primarily the result of the 2012 refinancing costs offset by an increase of approximately $2.7 million in interest expense due to an increase in borrowings outstanding, including debt assumed or incurred to finance 2012 acquisitions.  The 2012 refinancing costs related to the following: (i) $4.5 million prepayment penalties, (ii) $2.2 million deferred costs write-off and (iii) approximately $0.4 million expenses associated with the tender offer and redemption of our $175 million 7% 2016 Notes in the first quarter of 2012.

Funds From Operations

Our funds from operations available to common stockholders (“FFO”), for the three months ended March 31, 2013, was $70.1 million, compared to $48.2 million, for the same period in 2012.

We calculate and report FFO in accordance with the definition and interpretive guidelines issued by the National Association of Real Estate Investment Trusts (“NAREIT”), and, consequently, FFO is defined as net income available to common stockholders, adjusted for the effects of asset dispositions and certain non-cash items, primarily depreciation and amortization and impairment on real estate assets.  We believe that FFO is an important supplemental measure of our operating performance.  Because the historical cost accounting convention used for real estate assets requires depreciation (except on land), such accounting presentation implies that the value of real estate assets diminishes predictably over time, while real estate values instead have historically risen or fallen with market conditions.  The term FFO was designed by the real estate industry to address this issue.  FFO herein is not necessarily comparable to FFO of other REITs that do not use the same definition or implementation guidelines or interpret the standards differently from us.

FFO is a non-GAAP financial measure.  We use FFO as one of several criteria to measure operating performance of our business.  We further believe that by excluding the effect of depreciation, amortization, impairment on real estate assets and gains or losses from sales of real estate, all of which are based on historical costs and which may be of limited relevance in evaluating current performance, FFO can facilitate comparisons of operating performance between periods and between other REITs.  We offer this measure to assist the users of our financial statements in evaluating our financial performance under GAAP, and FFO should not be considered a measure of liquidity, an alternative to net income or an indicator of any other performance measure determined in accordance with GAAP.  Investors and potential investors in our securities should not rely on this measure as a substitute for any GAAP measure, including net income.

28

The following table presents our FFO results for the three- months ended March 31, 2013 and 2012:

	Three Months Ended
	March 31,
	2013		2012
	(in thousands)
Net income available to common stockholders	$	38,120	$	26,084
Deduct gain from real estate dispositions		—		(5,316	)
Sub-total		38,120		20,768
Elimination of non-cash items included in net income:
Depreciation and amortization		31,959		27,147
Add back impairments on real estate properties		—		272
Funds from operations available to common stockholders	$	70,079	$	48,187

Portfolio and Recent Developments

During the first quarter of 2013, we did not acquire any facilities.

Assets Held for Sale

At March 31, 2013, we had two SNFs and one parcel of land classified as held-for-sale with an aggregate net book value of approximately $1.0 million.

Liquidity and Capital Resources

At March 31, 2013, we had total assets of $3.0 billion, stockholders’ equity of $1.1 billion and debt of $1.8 billion, representing approximately 61.5% of total capitalization.

Financing Activities and Borrowing Arrangements

Certain of our other secured and unsecured borrowings are subject to customary affirmative and negative covenants, including financial covenants.  As of December 31, 2012 and March 31, 2013, we were in compliance with all affirmative and negative covenants, including financial covenants, for our secured and unsecured borrowings.

Bank Credit Agreements

We have a $700 million unsecured credit facility that we entered into on December 6, 2012, comprised of a $500 million unsecured revolving credit facility  (the “2012 Revolving Credit Facility”) and a $200 million unsecured, deferred draw term loan facility (the “2012 Term Loan Facility” and, together with the 2012 Revolving Credit Facility, collectively, the “2012 Credit Facilities”).

The 2012 Credit Facilities include an “accordion feature” that permits us to expand its borrowing capacity by a combined $300 million, to a total of $1 billion.

At March 31, 2013, we had no borrowings and no letters of credit outstanding under the 2012 Revolving Credit Facility. The 2012 Revolving Credit Facility matures on December 6, 2016, with an option by us to extend the maturity one additional year.  The 2012 Revolving Credit Facility is priced at LIBOR plus an applicable percentage (beginning at 150 basis points, with a range of 100 to 190 basis points) based on our ratings from Standard & Poor’s, Moody’s and/or Fitch Ratings, plus a facility fee based on the same ratings (initially 30 basis points, with a range of 15 to 45 basis points).

At March 31, 2013, the full $200 million was outstanding under the 2012 Term Loan Facility.  The 2012 Term Loan Facility is also priced at LIBOR plus an applicable percentage (beginning at 175 basis points, with a range of 110 to 230 basis points) based our ratings from Standard & Poor’s, Moody’s and/or Fitch Ratings.  At March 31, 2013, we borrowed the full $200 million under the 2012 Term Loan Facility.  The 2012 Term Loan Facility matures on December 6, 2017.

29

HUD Loans Payoff

During the second quarter of 2013, we notified Berkadia of our intent to retire the HUD Berkadia mortgages.  We anticipate using approximately $51.1 million in funds borrowed from our 2012 Credit Facility to repay the contractual portion of the HUD Berkadia Mortgages.  We also anticipate accelerating the amortization of the $11.4 million of premium associated with the HUD Berkadia mortgages.

HUD Mortgage Debt Refinancing

On March 26, 2013, we refinanced existing HUD mortgage debt on 12 properties in Arkansas for approximately $59.4 million including closing costs that were added to the outstanding balance.  The annual interest rate for the refinanced debt decreased from 5.55% to approximately 3.06%, with the term of the refinanced mortgages remaining unchanged.  For the three months ended March 31, 2013, we paid off a total of $58.9 million, including routine principal payments on the 12 Arkansas mortgage debts.

$250 Million Equity Shelf Program

On March 18, 2013, we entered into separate Equity Distribution Agreements (collectively, the “2013 Agreements”) to sell shares of our common stock having an aggregate gross sales price of up to $250 million (the “2013 ESP”) with several financial institutions, each as a sales agent and/or principal (collectively, the “Managers”).  Under the terms of the 2013 Agreements, we may sell shares of our common stock, from time to time, through or to the Managers having an aggregate gross sales price of up to $250 million.  Sales of the shares will be made by means of ordinary brokers’ transactions on the New York Stock Exchange at market prices, or as otherwise agreed with the applicable Manager.  We will pay each Manager compensation for sales of the shares equal to 2% of the gross sales price per share of shares sold through such Manager under the applicable 2013 Agreement.  We are not obligated to sell and the Managers are not obligated to buy or sell any shares under the 2013 Agreements.  No assurance can be given that we will sell any shares under the 2013 Agreements, or, if we do, as to the price or amount of shares that we sell, or the dates when such sales will take place.

For the three months ended March 31, 2013, we sold 1.5 million shares under the 2013 ESP, at an average price of $29.41 per share, generating gross proceeds of approximately $42.8 million, before $0.9 million of commissions.  Of the 1.5 million shares that we sold during the quarter, 0.6 million shares, representing gross proceeds of approximately $18.0 million had a settlement date in April 2013. We included net proceeds of $17.6 million as a receivable in other assets at March 31, 2013 with a corresponding increase in equity.

Termination of $245 Million Equity Shelf Program

Also on March 18, 2013, we terminated our $245 million Equity Shelf Program (the “2012 ESP”) that we entered into with several financial institutions on June 19, 2012.  For the three months ended March 31, 2013, we issued approximately 1.0 million shares under the 2012 ESP at an average price of $28.29 per share, generating gross proceeds of approximately $27.8 million, before $0.6 million commissions.

Since inception of the 2012 ESP, we have sold a total of 3.6 million shares of common stock generating total gross proceeds of $91.4 million under the program, before $1.9 million of commissions.  As a result of the termination of the 2012 ESP, no additional shares were issued under the 2012 ESP.

30

Dividend Reinvestment and Common Stock Purchase Plan

For the three-month period ended March 31, 2013, approximately 1.3 million shares of our common stock at average of $27.63 per share were issued through our Dividend Reinvestment and Common Stock Purchase Program for net proceeds of approximately $36.3 million.

Dividends

In order to qualify as a REIT, we are required to distribute dividends (other than capital gain dividends) to our stockholders in an amount at least equal to (A) the sum of (i) 90% of our “REIT taxable income” (computed without regard to the dividends paid deduction and our net capital gain), and (ii) 90% of the net income (after tax), if any, from foreclosure property, minus (B) the sum of certain items of non-cash income. In addition, if we dispose of any built-in gain asset during a recognition period, we will be required to distribute at least 90% of the built-in gain (after tax), if any, recognized on the disposition of such asset. Such distributions must be paid in the taxable year to which they relate, or in the following taxable year if declared before we timely file our tax return for such year and paid on or before the first regular dividend payment after such declaration. In addition, such distributions are required to be made pro rata, with no preference to any share of stock as compared with other shares of the same class, and with no preference to one class of stock as compared with another class except to the extent that such class is entitled to such a preference. To the extent that we do not distribute all of our net capital gain or do distribute at least 90%, but less than 100% of our “REIT taxable income” as adjusted, we will be subject to tax thereon at regular ordinary and capital gain corporate tax rates.

In addition, our 2012 Credit Agreement has certain financial covenants that limit the distribution of dividends paid during a fiscal quarter to no more than 95% of our aggregate cumulative FFO as defined in the credit agreement, unless a greater distribution is required to maintain REIT status.  Solely for purposes of the credit agreement, FFO is defined as net income (or loss) plus depreciation and amortization, adjusted to take into account our interests in unconsolidated partnerships and joint ventures, and further adjusted to exclude gains or losses resulting from: (i) restructuring our debt; (ii) sales of property; (iii) sales or redemptions of preferred stock; (iv) revenue or expenses related to owned and operated assets; (v) revenues or expenses related to FIN 46 consolidation requirements, (vi) cash litigation charges up to $10.0 million over the term of the credit agreement; (vii) non-cash charges associated with the write-down of accounts due to straight-line rent; (viii) other non-cash charges for accounts and notes receivable up to $20.0 million over the term of the credit agreement; (ix) certain non-cash compensation related expenses; (x) non-cash real property impairment charges; (xi) non-cash charges associated with the sale or settlement of derivative instruments; and (xii) charges related to acquisition deal-related costs.

For the three- months ended March 31, 2013, we paid total dividends of $50.6 million.

On April 16, 2013, the Board of Directors declared a common stock dividend of $0.46 per share, increasing the quarterly common dividend by $0.01 per share over the prior quarter, to be paid May 15, 2013 to common stockholders of record on April 30, 2013.

Liquidity

We believe our liquidity and various sources of available capital, including cash from operations, our existing availability under our 2012 Credit Facilities and expected proceeds from mortgage payoffs are adequate to finance operations, meet recurring debt service requirements and fund future investments through the next twelve months.

We regularly review our liquidity needs, the adequacy of cash flow from operations, and other expected liquidity sources to meet these needs.  We believe our principal short-term liquidity needs are to fund:

●           normal recurring expenses;

●           debt service payments;

31

●           common stock dividends; and

●           growth through acquisitions of additional properties.

The primary source of liquidity is our cash flows from operations.  Operating cash flows have historically been determined by: (i) the number of facilities we lease or have mortgages on; (ii) rental and mortgage rates; (iii) our debt service obligations; and (iv) general and administrative expenses.  The timing, source and amount of cash flows provided by financing activities and used in investing activities are sensitive to the capital markets environment, especially to changes in interest rates.  Changes in the capital markets environment may impact the availability of cost-effective capital and affect our plans for acquisition and disposition activity.

Cash and cash equivalents totaled $25.6 million as of March 31, 2013, an increase of $23.9 million as compared to the balance at December 31, 2012.  The following is a discussion of changes in cash and cash equivalents due to operating, investing and financing activities, which are presented in our Consolidated Statements of Cash Flows.

Operating Activities– Net cash flow from operating activities generated $57.6 million for the three months ended March 31, 2013, as compared to $49.5 million for the same period in 2012, an increase of $8.1 million.  The increase was primarily due to the additional cash flow from the facilities acquired and leased throughout 2012.

Investing Activities – Net cash flow from investing activities was an outflow of $11.5 million for the three months ended March 31, 2013, as compared to an inflow of $10.0 million for the same period in 2012.  The $21.5 million change in investing activities relates primarily to (i) a net cash outflow of $1.2 million from other investments – net in the first quarter of 2013, (ii) an additional $0.7 million investment in mortgage loans compared to the same period in 2012 and (iii) an additional $0.3 million investments in capital improvements projects compared to the same period in 2012.  Offsetting increases of the cash outflow were: (i) $14.1 million in proceeds from the sale of real estate in the first quarter of 2012, (ii) $1.9 million purchase of land in the first quarter of 2012 and (iii) a net cash inflow of $7.0 million from other investments – net in the first quarter of 2012.

Financing Activities – Net cash flow from financing activities was an outflow of $22.2 million for the three months ended March 31, 2013 as compared to an outflow of $57.2 million for the same period in 2012.  The $35.0 million decrease in cash outflow from financing activities was primarily a result of: (i) a net payment of $58 million on the 2012 Credit Facility during the first quarter of 2013 compared to $245.5 million of net payment on the 2011 Credit Facility for the same period in 2012; (ii) $59.4 million proceeds from HUD debt refinancing during the first quarter of 2013 compared to the issuance of our $400 million 2024 Notes in March 2012; (iii) a $60.0 million HUD mortgages payoff including routine HUD debt principal payments during the first quarter of 2013 compared to $175.0 million tender offer and redemption payments for our $175 million 2016 Notes and $1.0 million in routine HUD debt principal payments in the first quarter of 2012; (iv) a decrease in net payment of $11.7 million in deferred financing and refinancing costs in the first quarter of 2013 compared to the same period of 2012 primarily associated with (a) the tender offer and redemption of our $175 million 2016 Notes in the first quarter of 2012 and (b) the issuance of our $400 million 2024 Notes in the first quarter of 2012.  Offsetting these decreases were (i) an increase in net proceeds of $22.1 million from our dividend reinvestment plan during the first quarter of 2013 compared to the same period in 2012; (ii) an increase in net proceeds of $46.3 million from our common stock issued through our Equity Shelf Program during the first quarter of 2013 compared to the same period in 2012; (iii) an increase in dividend payments of $8.0 million related to an increase in number of shares outstanding and an increase of $0.04 per share in the dividends in the first quarter of 2013 compared to the same period in 2012.

32

Item 3 – Quantitative and Qualitative Disclosures about Market Risk

There have been no material changes in our primary market risk exposures or how those exposures are managed from the information disclosed under  Item 7A of our annual report on Form 10-K for the year ended December 31, 2012.

Item 4 – Controls and Procedures

Disclosure controls and procedures (as defined in Rule 13a-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) are controls and other procedures of an issuer that are designed to ensure that information required to be disclosed by the issuer in the reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms.  Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by an issuer in the reports that it files or submits under the Exchange Act is accumulated and communicated to the issuer’s management, including its principal executive and principal financial officers, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure.

In connection with the preparation of this Form 10-Q, we evaluated the effectiveness of the design and operation of our disclosure controls and procedures as of March 31, 2013.  Based on this evaluation, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures were effective at a reasonable assurance level as of March 31, 2013.

There were no changes in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) during the period covered by this report identified in connection with the evaluation of our disclosure controls and procedures described above that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

33

PART II – OTHER INFORMATION

Item 1 – Legal Proceedings

See Note 9 – Litigation to the Consolidated Financial Statements in Part I, Item 1 hereto, which is hereby incorporated by reference in response to this item.

Item 1A – Risk Factors

We filed our Annual Report on Form 10-K for the year ended December 31, 2012, with the Securities and Exchange Commission on February 28, 2013, which sets forth our risk factors in Item 1A therein.  We have not experienced any material changes from the risk factors previously described therein.

34

Item 6–Exhibits

Exhibit No.
10.1	Form of Equity Distribution Agreement, dated March 18, 2013, entered into by and between Omega Healthcare Investors, Inc. and each of BB&T Capital Markets, a division of BB&T Securities, LLC, Credit Agricole Securities (USA) Inc., J.P. Morgan Securities LLC, Merrill Lynch, Pierce, Fenner & Smith Incorporated, Morgan Stanley & Co. LLC,  RBC Capital Markets, LLC, RBS Securities Inc., Stifel, Nicolaus & Company, Incorporated, SunTrust Robinson Humphrey, Inc. and UBS Securities LLC. (Incorporated by reference to Exhibit 1.1 of the Company’s Current Report on Form 8-K, filed March 19, 2013).
31.1	Rule 13a-14(a)/15d-14(a) Certification of the Chief Executive Officer.
31.2	Rule 13a-14(a)/15d-14(a) Certification of the Chief Financial Officer.
32.1	Section 1350 Certification of the Chief Executive Officer.
32.2	Section 1350 Certification of the Chief Financial Officer.
101.INS	XBRL Instance Document.**
101.SCH	XBRL Taxonomy Extension Schema Document.**
101.CAL	XBRL Taxonomy Extension Calculation Linkbase Document.**
101.DEF	XBRL Taxonomy Extension Definition Linkbase Document.**
101.LAB	XBRL Taxonomy Extension Label Linkbase Document.**
101.PRE	XBRL Taxonomy Extension Presentation Linkbase Document.**

**In accordance with Rule 406T of Regulation S-T, this XBRL-related information shall be deemed to be “furnished” and not “filed.”

35

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

OMEGA HEALTHCARE INVESTORS, INC.

Registrant

Date:           May 9, 2013	By:	/S/ C. TAYLOR PICKETT
		C. Taylor Pickett
		Chief Executive Officer
Date:           May 9, 2013	By:	/S/ ROBERT O. STEPHENSON
		Robert O. Stephenson
		Chief Financial Officer

36

EX-31.1

Exhibit 31.1

RULE 13a-14(a)/15d-14(a) CERTIFICATION OF CHIEF EXECUTIVE OFFICER

Certification

I, C. Taylor Pickett, certify that:

1. I have reviewed this Quarterly Report on Form 10-Q of Omega Healthcare Investors, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a. Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b. Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c. Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d. Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a. All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b. Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date:           May 9, 2013	/S/ C. TAYLOR PICKETT
	C. Taylor Pickett
	Chief Executive Officer

EX-31.2

Exhibit 31.2

RULE 13a-14(a)/15d-14(a) CERTIFICATION OF CHIEF FINANCIAL OFFICER

Certifications

I, Robert O. Stephenson, certify that:

1. I have reviewed this Quarterly Report on Form 10-Q of Omega Healthcare Investors, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a. Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b. Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c. Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d. Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a. All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b. Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date:           May 9, 2013	/S/ ROBERT O. STEPHENSON
	Robert O. Stephenson
	Chief Financial Officer

EX-32.1

EXHIBIT 32.1

SECTION 1350 CERTIFICATION

OF THE CHIEF EXECUTIVE OFFICER

I, C. Taylor Pickett, hereby certify, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. Section 1350, that to the best of my knowledge:

(1) the Quarterly Report on Form 10-Q of the Company for the three months ended March 31, 2013 (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

(2) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date:           May 9, 2013

/S/	C. TAYLOR PICKETT
	C. Taylor Pickett Chief Executive Officer

EX-32.2

EXHIBIT 32.2

SECTION 1350 CERTIFICATION

OF THE CHIEF FINANCIAL OFFICER

I, Robert O. Stephenson, hereby certify, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. Section 1350, that, to the best of my knowledge:

(1) the Quarterly Report on Form 10-Q of the Company for the three months ended March 31, 2013 (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

(2) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date:           May 9, 2013

/S/	ROBERT O. STEPHENSON
	Robert O. Stephenson Chief Financial Officer

XML

STOCK-BASED COMPENSATION (Narrative) (Detail) 2 (USD $) In Millions, except Share data, unless otherwise specified	3 Months Ended
	Mar. 31, 2013
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares of restricted stock outstanding	925,480
Restricted stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares of restricted stock outstanding	428,503
Restricted stock | Directors
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares of restricted stock outstanding	21,957
Vesting period, years	3 years
Unrecognized compensation cost	$ 0.3

XML

SUBSEQUENT EVENTS (Narrative) (Detail) (Subsequent Event, USD $)	3 Months Ended
	Jun. 30, 2013 HUD Berkedia mortgages	May 31, 2013 $25 Million Mezzanine Loan
Subsequent Event [Line Items]
Mezzanine loan, principal amount		$ 24,700,000
Mezzanine loan, Interest rate		12.00%
Mortgage Loans Payoff	51,100,000
Amortization of premium	$ 11,400,000

XML

CONSOLIDATING FINANCIAL STATEMENTS (Detail 1) (USD $) In Thousands, unless otherwise specified	3 Months Ended
	Mar. 31, 2013	Mar. 31, 2012
Revenue
Rental income	$ 93,109	$ 75,975
Mortgage interest income	7,346	7,336
Other investment income - net	1,306	1,130
Miscellaneous		74
Total operating revenues	101,761	84,515
Expenses
Depreciation and amortization	31,959	27,147
General and administrative	5,197	5,526
Acquisition costs	134	105
Impairment on real estate properties		272
Nursing home expenses of owned and operated assets
Total operating expenses	37,290	33,050
Income before other income and expense	64,471	51,465
Other income (expense)
Interest income	3	7
Interest expense	(25,672)	(22,967)
Interest - amortization of deferred financing costs	(682)	(629)
Interest - refinancing costs		(7,108)
Equity in earnings
Total other expense	(26,351)	(30,697)
Income Before Gain Loss On Assets Sold	38,120	20,768
Gain (Loss) On Disposition Of Assets		5,316
Net income available to common stockholders	38,120	26,084
Issuer & Subsidiary Guarantors
Revenue
Rental income	77,641	63,964
Mortgage interest income	7,346	7,336
Other investment income - net	1,306	1,130
Miscellaneous		74
Total operating revenues	86,293	72,504
Expenses
Depreciation and amortization	25,575	21,899
General and administrative	5,082	5,414
Acquisition costs	134	105
Impairment on real estate properties		272
Total operating expenses	30,791	27,690
Income before other income and expense	55,502	44,814
Other income (expense)
Interest income	(5)
Interest expense	(20,774)	(19,107)
Interest - amortization of deferred financing costs	(682)	(629)
Interest - refinancing costs		(7,108)
Equity in earnings	4,079	2,798
Total other expense	(17,382)	(24,046)
Income Before Gain Loss On Assets Sold		20,768
Gain (Loss) On Disposition Of Assets		5,316
Net income available to common stockholders	38,120	26,084
Non-guarantor subsidiaries
Revenue
Rental income	15,468	12,011
Mortgage interest income
Other investment income - net
Miscellaneous
Total operating revenues	15,468	12,011
Expenses
Depreciation and amortization	6,384	5,248
General and administrative	115	112
Acquisition costs
Impairment on real estate properties
Total operating expenses	6,499	5,360
Income before other income and expense	8,969	6,651
Other income (expense)
Interest income	8	7
Interest expense	(4,898)	(3,860)
Interest - amortization of deferred financing costs
Interest - refinancing costs
Equity in earnings
Total other expense	(4,890)	(3,853)
Income Before Gain Loss On Assets Sold		2,798
Gain (Loss) On Disposition Of Assets
Net income available to common stockholders	4,079	2,798
Elimination Company
Revenue
Rental income
Mortgage interest income
Other investment income - net
Miscellaneous
Total operating revenues
Expenses
Depreciation and amortization
General and administrative
Acquisition costs
Impairment on real estate properties
Total operating expenses
Income before other income and expense
Other income (expense)
Interest income
Interest expense
Interest - amortization of deferred financing costs
Interest - refinancing costs
Equity in earnings	(4,079)	(2,798)
Total other expense	(4,079)	(2,798)
Income Before Gain Loss On Assets Sold		(2,798)
Gain (Loss) On Disposition Of Assets
Net income available to common stockholders	$ (4,079)	$ (2,798)

XML

CONCENTRATION OF RISK (Narrative) (Detail) (USD $)	3 Months Ended
	Mar. 31, 2013 Operator Facility State	Mar. 31, 2012	Dec. 31, 2012
Concentration Risk [Line Items]
Number of facilities owned	479
Number of states	34
Number of operators	46
Gross investment in facilities, net of impairments and before reserve for uncollectible loans	$ 3,300,000,000
Percentage share of real estate investments related to long-term care facilities	99.00%
Miscellaneous investments, net	48,537,000		47,339,000
Operated, concentration percent for separate disclosure	10.00%
Operated, concentration number	2
Revenues from operations	101,761,000	84,515,000
Florida
Concentration Risk [Line Items]
Concentration percent by state	18.00%
Ohio
Concentration Risk [Line Items]
Concentration percent by state	11.00%
Indiana
Concentration Risk [Line Items]
Concentration percent by state	10.00%
CommuniCare
Concentration Risk [Line Items]
Operated, concentration percent	10.00%
Revenues from operations	11,100,000
Revenues from operations, percentage	11.00%
Genesis Healthcare
Concentration Risk [Line Items]
Operated, concentration percent	11.00%
Revenues from operations	$ 13,800,000
Revenues from operations, percentage	14.00%
SNF's
Concentration Risk [Line Items]
Number of facilities owned	418
Number of held-for-sale facilities	2
Number of facilities under fixed rate mortgage loan	32
ALFs
Concentration Risk [Line Items]
Number of facilities owned	16
Specialty facilities
Concentration Risk [Line Items]
Number of facilities owned	11

XML

FINANCIAL INSTRUMENTS (Tables)

3 Months Ended

Mar. 31, 2013

Fair Value Disclosures [Abstract]

Schedule of the carrying amounts and fair values of financial instruments

At March 31, 2013 and December 31, 2012, the carrying amounts and fair values of our financial instruments were as follows:

	March 31, 2013				December 31, 2012
	Carrying Amount		Fair Value		Carrying Amount		Fair Value
Assets:	(in thousands)
Cash and cash equivalents	$	25,611	$	25,611	$	1,711	$	1,711
Restricted cash		34,377		34,377		36,660		36,660
Mortgage notes receivable – net		240,551		238,145		238,621		235,705
Other investments – net		48,537		45,427		47,339		44,077
Totals	$	349,076	$	343,560	$	324,331	$	318,153
Liabilities:
Revolving line of credit	$	—	$	—	$	158,000	$	158,000
Term loan		200,000		200,000		100,000		100,000
7.50% Notes due 2020 – net		197,632		253,145		197,546		252,363
6.75% Notes due 2022 – net		581,626		732,702		581,799		724,240
5.875% Notes due 2024 – net		400,000		437,027		400,000		441,761
HUD debt		365,428		412,821		366,538		433,803
Subordinated debt		21,008		27,771		21,049		27,896
Totals	$	1,765,694	$	2,063,466	$	1,824,932	$	2,138,063

XML

FINANCING ACTIVITIES AND BORROWING ARRANGEMENTS (Narrative) (Detail 2) (USD $)	3 Months Ended		1 Months Ended	3 Months Ended	1 Months Ended	3 Months Ended	1 Months Ended	3 Months Ended
	Mar. 31, 2013	Mar. 31, 2013 Other assets	Mar. 18, 2013 $250 Million Equity Shelf Program	Mar. 31, 2013 $250 Million Equity Shelf Program	Mar. 18, 2013 Termination of $245 Million Equity Shelf Program	Mar. 31, 2013 Termination of $245 Million Equity Shelf Program	Mar. 26, 2013 HUD Mortgage Debt Refinancing Property	Mar. 31, 2013 HUD Mortgage Debt Refinancing Property
Debt Instrument [Line Items]
Principal payment for mortgage							$ 59,400,000	$ 58,900,000
Number of Arkansas mortgage debts paid off							12	12
Weighted average annual interest rate							5.55%
Reduction in annual interest rate for the refinanced debt							3.06%
Sales price, equity distribution agreement			250,000,000		245,000,000
Stock issued	2,440,000			1,500,000	3,600,000	1,000,000
Average price per share (in dollars per share)	$ 27.63			$ 29.41		$ 28.29
Gross proceeds from issue of common stock, before commissions				42,800,000	91,400,000	27,800,000
Commissions on sale of common stock				900,000	1,900,000	600,000
Part of new stock issued				600,000
Proceeds from part of new stock issued				18,000,000
Net proceeds receivable for sale of common stock		17,600,000
Dividend reinvestment plan	1,315,000
Net proceeds from shares issued under Dividend Reinvestment and Common Stock Purchase Program	$ 36,330,000
Manager compensation, percentage of gross sales price per share sold			2.00%

XML

STOCK-BASED COMPENSATION (Detail 2) (USD $) In Millions, except Share data, unless otherwise specified	3 Months Ended
	Mar. 31, 2013
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares/Units	925,480
Grant Date Average Fair Value Per Unit/ Share	14.93
Total Compensation Cost	14.9
Unrecognized Compensation Cost	4.7
Performance restricted stock units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Method used to estimate the fair value for PRSUs	Monte Carlo model
Performance restricted stock units | Annual TSR
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares/Units	124,244
Grant Date Average Fair Value Per Unit/ Share	8.92
Total Compensation Cost	1.1
Weighted Average Period of Expense Recognition	12 months
Unrecognized Compensation Cost	0.8
Performance restricted stock units | Multi-year Absolute TSR
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares/Units	279,550
Grant Date Average Fair Value Per Unit/ Share	11.06
Total Compensation Cost	3.1
Weighted Average Period of Expense Recognition	44 months
Unrecognized Compensation Cost	1.1
Performance restricted stock units | Multi-year Relative TSR
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares/Units	93,183
Grant Date Average Fair Value Per Unit/ Share	12.26
Total Compensation Cost	1.1
Weighted Average Period of Expense Recognition	44 months
Unrecognized Compensation Cost	0.4
Restricted stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares/Units	428,503
Grant Date Average Fair Value Per Unit/ Share	22.44
Total Compensation Cost	9.6
Weighted Average Period of Expense Recognition	36 months
Unrecognized Compensation Cost	2.4

XML

CONSOLIDATING FINANCIAL STATEMENTS (Narrative) (Detail) (USD $)	3 Months Ended						3 Months Ended				3 Months Ended	1 Months Ended	3 Months Ended
	Mar. 31, 2013 Non-guarantor subsidiaries	Mar. 31, 2012 Non-guarantor subsidiaries	Jun. 29, 2010 CapitalSource Non-guarantor subsidiaries Subsidiaries	Mar. 31, 2013 7.50% Notes due 2020	Mar. 31, 2013 6.75% Notes due 2022	Mar. 31, 2013 5.875% Notes due 2024	Mar. 31, 2013 HUD debt Non-guarantor subsidiaries	Dec. 31, 2012 HUD debt Non-guarantor subsidiaries Subsidiaries	Jul. 31, 2012 HUD debt Non-guarantor subsidiaries Subsidiaries	Dec. 31, 2011 HUD debt Non-guarantor subsidiaries Subsidiaries	Mar. 31, 2013 HUD debt Guarantor subsidiaries	Mar. 26, 2013 HUD Mortgage Debt Refinancing Property	Mar. 31, 2013 HUD Mortgage Debt Refinancing Property
Condensed Financial Statements, Captions [Line Items]
Senior notes, principal amount				$ 200,000,000	$ 575,000,000	$ 400,000,000
Rate on senior notes				7.50%	6.75%	5.875%
Number of subsidiaries acquired and designated as unrestricted			39					8		20
Number of unrestricted subsidiaries removed due to retirement of HUD related mortgages									5
Principal payment for mortgage	1,100,000	1,000,000										59,400,000	58,900,000
Closing cost													$ 500,000
Ownership percent of the subsidiary guarantors (in percent)							100.00%				100.00%
Number of Arkansas mortgage debts paid off												12	12
Weighted average interest rate												5.55%
Reduction in annual interest rate for the refinanced debt												3.06%

XML

PROPERTIES AND INVESTMENTS

3 Months Ended

Mar. 31, 2013

Real Estate [Abstract]

PROPERTIES AND INVESTMENTS

NOTE 2 – PROPERTIES AND INVESTMENTS

In the ordinary course of our business activities, we periodically evaluate investment opportunities and extend credit to customers.  We also regularly engage in lease and/or loan extensions and modifications. Additionally, we actively monitor and manage our investment portfolio with the objectives of improving credit quality and increasing investment returns.  In connection with our portfolio management, we may engage in various collection and foreclosure activities.

If we acquire real estate pursuant to a foreclosure or bankruptcy proceeding, the assets will initially be included on the consolidated balance sheet at the lower of cost or estimated fair value.

Leased Property

Our leased real estate properties, represented by 418 SNFs, 16 assisted living facilities (“ALFs”) and 11 specialty facilities at March 31, 2013, are leased under provisions of single or master leases with initial terms typically ranging from 5 to 15 years, plus renewal options.  Substantially all of our leases contain provisions for specified annual increases over the rents of the prior year and are generally computed in one of three methods depending on specific provisions of each lease as follows: (i) a specific annual percentage increase over the prior year’s rent, generally 2.5%; (ii) an increase based on the change in pre-determined formulas from year to year (i.e., such as increases in the Consumer Price Index (“CPI”)); or (iii) specific dollar increases over prior years.  Under the terms of the leases, the lessee is responsible for all maintenance, repairs, taxes and insurance on the leased properties.

The facilities acquired in 2012 are included in our results of operations from the date of acquisition.  The following unaudited pro forma results of operations reflect the impact of the transactions as if they occurred on January 1, 2012.  In the opinion of management, all significant necessary adjustments to reflect the effect of the acquisitions have been made.  The following pro forma information is not indicative of future operations.

	Pro Forma
	Three Months Ended
	March 31,
	2013		2012
	(in thousands, except per share amounts, unaudited)
Revenues	$	101,761	$	98,021
Net income available to common stockholders		38,120		31,690
Earnings per share – diluted:
Net income available to common stockholders – as reported	$	0.34	$	0.25
Net income available to common stockholders – pro forma		0.34		0.30

Assets Held for Sale

At March 31, 2013, we had two SNFs and one parcel of land classified as held-for-sale with an aggregate net book value of approximately $1.0 million.

Mortgage Notes Receivables

Our mortgage notes receivables relate to 13 fixed-rate mortgages on 32 long-term care facilities and one construction mortgage on one facility currently under construction.  The mortgage notes are secured by first mortgage liens on the borrowers’ underlying real estate and personal property.  The mortgage notes receivable relate to facilities located in five (5) states, which are operated by five (5) independent healthcare operating companies.  We monitor compliance with mortgages and when necessary have initiated collection, foreclosure and other proceedings with respect to certain outstanding loans.  As of March 31, 2013, none of our mortgages were in default or in foreclosure proceedings.  Where appropriate, the mortgage properties are generally cross-collateralized with the master lease agreement.

Mortgage interest income is recognized as earned over the terms of the related mortgage notes, using the effective yield method.  Allowances are provided against earned revenues from mortgage interest when collection of amounts due becomes questionable or when negotiations for restructurings of troubled operators lead to lower expectations regarding ultimate collection.  When collection is uncertain, mortgage interest income on impaired mortgage loans is recognized as received after taking into account application of security deposits.

XML

FINANCIAL INSTRUMENTS (Detail) (USD $)	Mar. 31, 2013	Dec. 31, 2012	Mar. 31, 2012	Dec. 31, 2011
Assets:
Cash and cash equivalents	$ 25,611,000	$ 1,711,000	$ 2,717,000	$ 351,000
Restricted cash	34,377,000	36,660,000
Mortgage notes receivable - net	240,551,000	238,621,000
Other investments - net	48,537,000	47,339,000
Liabilities:
HUD debt	365,428,000	366,538,000
Carrying Amount
Assets:
Cash and cash equivalents	25,611,000	1,711,000
Restricted cash	34,377,000	36,660,000
Mortgage notes receivable - net	240,551,000	238,621,000
Other investments - net	48,537,000	47,339,000
Totals	349,076,000	324,331,000
Liabilities:
Revolving line of credit		158,000,000
Term loan	200,000,000	100,000,000
HUD debt	365,428,000	366,538,000
Subordinated debt	21,008,000	21,049,000
Totals	1,765,694,000	1,824,932,000
Carrying Amount | 7.50% Notes due 2020
Liabilities:
Notes Payable	197,632,000	197,546,000
Carrying Amount | 6.75% Notes due 2022
Liabilities:
Notes Payable	581,626,000	581,799,000
Carrying Amount | 5.875% Notes due 2024
Liabilities:
Notes Payable	400,000,000	400,000,000
Fair Value
Assets:
Cash and cash equivalents	25,611,000	1,711,000
Restricted cash	34,377,000	36,660,000
Mortgage notes receivable - net	238,145,000	235,705,000
Other investments - net	45,427,000	44,077,000
Totals	343,560,000	318,153,000
Liabilities:
Revolving line of credit		158,000,000
Term loan	200,000,000	100,000,000
HUD debt	412,821,000	433,803,000
Subordinated debt	27,771,000	27,896,000
Totals	2,063,466,000	2,138,063,000
Fair Value | 7.50% Notes due 2020
Liabilities:
Notes Payable	253,145,000	252,363,000
Fair Value | 6.75% Notes due 2022
Liabilities:
Notes Payable	732,702,000	724,240,000
Fair Value | 5.875% Notes due 2024
Liabilities:
Notes Payable	$ 437,027,000	$ 441,761,000

XML

PROPERTIES AND INVESTMENTS (Detail) (USD $) In Thousands, except Per Share data, unless otherwise specified	3 Months Ended
	Mar. 31, 2013	Mar. 31, 2012
Earnings per share - diluted:
Net income available to common stockholders - as reported	$ 0.34	$ 0.25
Pro forma
Proforma Information [Line Items]
Revenues	$ 101,761	$ 98,021
Net income available to common stockholders	$ 38,120	$ 31,690
Earnings per share - diluted:
Net income available to common stockholders - as reported	$ 0.34	$ 0.25
Net income available to common stockholders - pro forma	$ 0.34	$ 0.30

XML

BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES (Detail) (USD $) In Thousands, unless otherwise specified	Mar. 31, 2013	Dec. 31, 2012
Organization, Consolidation and Presentation Of Financial Statements [Abstract]
Contractual receivables	$ 3,269	$ 3,963
Effective yield interest receivables	4,121	3,576
Straight-line receivables	104,983	98,973
Lease inducements	18,465	19,307
Allowance	(580)	(639)
Accounts receivable - net	$ 130,258	$ 125,180

XML

EARNINGS PER SHARE (Detail) (USD $) In Thousands, except Per Share data, unless otherwise specified	3 Months Ended
	Mar. 31, 2013	Mar. 31, 2012
Numerator:
Net income	$ 38,120	$ 26,084
Numerator for net income available to common per share - basic and diluted	$ 38,120	$ 26,084
Denominator:
Denominator for basic earnings per share	112,782	103,754
Effect of dilutive securities:
Restricted stock	714	241
Deferred stock	26	17
Denominator for diluted earnings per share	113,522	104,012
Earnings per share - basic:
Net income - basic	$ 0.34	$ 0.25
Earnings per share - diluted:
Net income - diluted	$ 0.34	$ 0.25

XML

PROPERTIES AND INVESTMENTS - Leased Property (Narrative) (Detail)	3 Months Ended
	Mar. 31, 2013 Facility
Leased Properties [Line Items]
Number of leased real estate properties	479
Increase in the specific annual percentage over the prior year's rent	2.50%
Property available for operating lease | Minimum
Leased Properties [Line Items]
Lease term	5 years
Property available for operating lease | Maximum
Leased Properties [Line Items]
Lease term	15 years
SNF's
Leased Properties [Line Items]
Number of leased real estate properties	418
ALFs
Leased Properties [Line Items]
Number of leased real estate properties	16
Specialty facilities
Leased Properties [Line Items]
Number of leased real estate properties	11

XML

PROPERTIES AND INVESTMENTS - Assets Sold or Held for Sale (Narrative) (Detail 2) (SNF's, USD $) In Millions, unless otherwise specified	Mar. 31, 2013 Parcel Property
SNF's
Real Estate Properties [Line Items]
Number of held-for-sale facilities	2
Number of parcels of land held-for-sale	1
Net book value of held-for-sale	1.0

XML

BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES

3 Months Ended

Mar. 31, 2013

Accounting Policies [Abstract]

BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES

NOTE 1 – BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES

Business Overview

Omega Healthcare Investors, Inc. (“Omega” or the “Company”) has one reportable segment consisting of investments in healthcare-related real estate properties.  Our core business is to provide financing and capital to the long-term healthcare industry with a particular focus on skilled nursing facilities (“SNFs”) located in the United States.  Our core portfolio consists of long-term leases and mortgage agreements.  All of our leases are “triple-net” leases, which require the tenants to pay all property-related expenses.  Our mortgage revenue derives from fixed-rate mortgage loans, which are secured by first mortgage liens on the underlying real estate and personal property of the mortgagor.

Basis of Presentation

The accompanying unaudited consolidated financial statements for Omega have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”) regarding interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X.  Accordingly, they do not include all of the information and notes required by U.S. generally accepted accounting principles (“GAAP”) for complete financial statements.  In our opinion, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included. We have evaluated all subsequent events through the date of the filing of this Form 10-Q.These unaudited consolidated financial statements should be read in conjunction with the financial statements and the footnotes thereto included in our latest Annual Report on Form 10-K.

Our consolidated financial statements include the accounts of (i) Omega, (ii) all direct and indirect wholly owned subsidiaries of Omega, and (iii) TC Healthcare, a variable interest entity (“VIE”) that we consolidate as the primary beneficiary.  All inter-company accounts and transactions have been eliminated in consolidation of the financial statements.

Accounts Receivable
 

Accounts receivable includes: contractual receivables, effective yield interest receivables, straight-line rent receivables and lease inducements, net of an estimated provision for losses related to uncollectible and disputed accounts.  Contractual receivables relate to the amounts currently owed to us under the terms of our lease and loan agreements.  Effective yield interest receivables relate to the difference between the interest income recognized on an effective yield basis over the term of the loan agreement and the interest currently due to us according to the contractual agreement. Straight-line receivables relate to the difference between the rental revenue recognized on a straight-line basis and the amounts currently due to us according to the contractual agreement.  Lease inducements result from value provided by us to the lessee at the inception or renewal of the lease and will be amortized as a reduction of rental revenue over the non cancellable lease term. 

On a quarterly basis, we review our accounts receivable to determine their collectability.  The determination of collectability of these assets requires significant judgment and is affected by several factors relating to the credit quality of our operators that we regularly monitor, including (i) payment history, (ii) the age of the contractual receivables, (iii) the current economic conditions and reimbursement environment, (iv) the ability of the tenant to perform under the terms of their lease and/or contractual loan agreements and (v) the value of the underlying collateral of the agreement.  If we determine collectability of any of our contractual receivables is at risk, we estimate the potential uncollectible amounts and provide an allowance.  In the case of a lease recognized on a straight-line basis or existence of lease inducements, we generally provide an allowance for straight-line accounts receivable and/or the lease inducements when certain conditions or indicators of adverse collectability are present.

A summary of our net receivables by type is as follows:

	March 31, 2013			December 31, 2012
	(in thousands)
Contractual receivables	$	3,269		$	3,963
Effective yield interest receivables		4,121			3,576
Straight-line receivables		104,983			98,973
Lease inducements		18,465			19,307
Allowance		(580	)		(639	)
Accounts receivable – net	$	130,258		$	125,180

We continuously evaluate the payment history and financial strength of our operators and have historically established allowance reserves for straight-line rent adjustments for operators that do not meet our requirements.  We consider factors such as payment history and the operator’s financial condition as well as current and future anticipated operating trends when evaluating whether to establish allowance reserves.

XML

PROPERTIES AND INVESTMENTS - Mortgage Notes Receivables (Narrative) (Detail 3)	Mar. 31, 2013 State Operator Facility
Real Estate Properties [Line Items]
Number of facilities owned	479
Number of states	34
Number of operators	46
Mortgage Receivable
Real Estate Properties [Line Items]
Number of states	5
Number of operators	5
Mortgage Receivable | Long-term care facilities
Real Estate Properties [Line Items]
Number of facilities owned	32
Mortgage Receivable | Construction Mortgages
Real Estate Properties [Line Items]
Number of underlying mortgage loans	13
Number of real estate properties under construction	1

XML

FINANCING ACTIVITIES AND BORROWING ARRANGEMENTS - Long-term borrowings (Detail) (USD $)	3 Months Ended
	Mar. 31, 2013		Dec. 31, 2012
Debt Instrument [Line Items]
HUD debt	$ 365,428,000		$ 366,538,000
Revolving line of credit	200,000,000		258,000,000
Totals - net	1,765,694,000		1,824,932,000
2020 Notes
Debt Instrument [Line Items]
Senior notes outstanding	200,000,000
2022 Notes
Debt Instrument [Line Items]
Senior notes outstanding	575,000,000
2024 Notes
Debt Instrument [Line Items]
Senior notes outstanding	400,000,000
Secured borrowings
Debt Instrument [Line Items]
HUD debt	365,428,000		366,538,000
Secured borrowings | HUD Berkadia mortgages assumed June 2010
Debt Instrument [Line Items]
Maturity	2036 - 2040	[1]
Current Rate	6.61%	[1]
Long-term borrowing amount, secured borrowings	62,515,000	[1]	62,921,000	[1]
Secured borrowings | HUD Capital Funding mortgages assumed June 2010
Debt Instrument [Line Items]
Maturity	2040 - 2045	[1]
Current Rate	4.85%	[1]
Long-term borrowing amount, secured borrowings	130,332,000	[1]	130,887,000	[1]
Secured borrowings | HUD mortgages assumed October 2011
Debt Instrument [Line Items]
Maturity	2036 - 2040	[1]
Current Rate	4.87%	[1]
Long-term borrowing amount, secured borrowings	31,782,000	[1]	31,991,000	[1]
Secured borrowings | HUD mortgages assumed December 2011
Debt Instrument [Line Items]
Maturity	2044	[1]
Current Rate	3.06%	[1]
Long-term borrowing amount, secured borrowings	59,355,000	[1]	58,884,000	[1]
Secured borrowings | HUD mortgages assumed December 2012
Debt Instrument [Line Items]
Maturity	2031 - 2045	[1]
Current Rate	5.50%	[1]
Long-term borrowing amount, secured borrowings	81,444,000	[1]	81,855,000	[1]
Unsecured borrowings
Debt Instrument [Line Items]
Unsecured borrowing	1,196,008,000		1,196,049,000
Premium - net	4,258,000		4,345,000
Total unsecured borrowings	1,400,266,000		1,458,394,000
Unsecured borrowings | Revolving line of credit
Debt Instrument [Line Items]
Maturity	2016
Current Rate
Revolving line of credit			158,000,000
Unsecured borrowings | Term loan
Debt Instrument [Line Items]
Maturity	2017
Current Rate	1.95%
Term loan	200,000,000		100,000,000
Unsecured borrowings | 2020 Notes
Debt Instrument [Line Items]
Maturity	2020
Current Rate	7.50%
Senior notes outstanding	200,000,000		200,000,000
Unsecured borrowings | 2022 Notes
Debt Instrument [Line Items]
Maturity	2022
Current Rate	6.75%
Senior notes outstanding	575,000,000		575,000,000
Unsecured borrowings | 2024 Notes
Debt Instrument [Line Items]
Maturity	2024	[1]
Current Rate	5.875%
Senior notes outstanding	400,000,000		400,000,000
Unsecured borrowings | Subordinated debt
Debt Instrument [Line Items]
Maturity	2021
Current Rate	9.00%
Subordinated debt	$ 21,008,000		$ 21,049,000

[1] Reflects the weighted average annual interest rate on the mortgages.

XML

CONSOLIDATED BALANCE SHEETS (USD $) In Thousands, unless otherwise specified	Mar. 31, 2013	Dec. 31, 2012	Mar. 31, 2012	Dec. 31, 2011
Real estate properties
Land and buildings	$ 3,046,805	$ 3,038,553
Less accumulated depreciation	(612,302)	(580,373)
Real estate properties - net	2,434,503	2,458,180
Mortgage notes receivable - net	240,551	238,621
Real estate properties, total	2,675,054	2,696,801
Other investments - net	48,537	47,339
Total investments held, continuing operations	2,723,591	2,744,140
Assets held for sale - net	1,020	1,020
Total investments	2,724,611	2,745,160
Cash and cash equivalents	25,611	1,711	2,717	351
Restricted cash	34,377	36,660
Accounts receivable - net	130,258	125,180
Other assets	89,784	73,294
Total assets	3,004,641	2,982,005
LIABILITIES AND STOCKHOLDERS' EQUITY
Revolving line of credit	200,000	258,000
Secured borrowings	365,428	366,538
Unsecured borrowings - net	1,200,266	1,200,394
Accrued expenses and other liabilities	133,193	145,744
Total liabilities	1,898,887	1,970,676
Stockholders' equity:
Common stock $.10 par value 200,000 shares authorized - 116,153 shares as of March 31, 2013 and 112,393 as of December 31, 2012 issued and outstanding	11,615	11,239
Common stock - additional paid-in capital	1,771,374	1,664,855
Cumulative net earnings	792,248	754,128
Cumulative dividends paid	(1,469,483)	(1,418,893)
Total stockholders' equity	1,105,754	1,011,329
Total liabilities and stockholders' equity	$ 3,004,641	$ 2,982,005

XML

CONSOLIDATING FINANCIAL STATEMENTS (Detail) (USD $) In Thousands, unless otherwise specified	Mar. 31, 2013	Dec. 31, 2012	Mar. 31, 2012	Dec. 31, 2011
Real estate properties
Land and buildings	$ 3,046,805	$ 3,038,553
Less accumulated depreciation	(612,302)	(580,373)
Real estate properties - net	2,434,503	2,458,180
Mortgage notes receivable - net	240,551	238,621
Real estate properties, total	2,675,054	2,696,801
Other investments - net	48,537	47,339
Total investments held, continuing operations	2,723,591	2,744,140
Assets held for sale - net	1,020	1,020
Total investments	2,724,611	2,745,160
Cash and cash equivalents	25,611	1,711	2,717	351
Restricted cash	34,377	36,660
Accounts receivable - net	130,258	125,180
Investment in affiliates
Other assets	89,784	73,294
Total assets	3,004,641	2,982,005
LIABILITIES AND STOCKHOLDERS' EQUITY
Revolving line of credit	200,000	258,000
Secured borrowings	365,428	366,538
Unsecured borrowings - net	1,200,266	1,200,394
Accrued expenses and other liabilities	133,193	145,744
Intercompany payable
Total liabilities	1,898,887	1,970,676
Stockholders' equity:
Common stock	11,615	11,239
Common stock - additional paid-in capital	1,771,374	1,664,855
Cumulative net earnings	792,248	754,128
Cumulative dividends paid	(1,469,483)	(1,418,893)
Total stockholders' equity	1,105,754	1,011,329
Total liabilities and stockholders' equity	3,004,641	2,982,005
Issuer & Subsidiary Guarantors
Real estate properties
Land and buildings	2,475,194	2,466,866
Less accumulated depreciation	(560,768)	(535,223)
Real estate properties - net	1,914,426	1,931,643
Mortgage notes receivable - net	240,551	238,621
Real estate properties, total	2,154,977	2,170,264
Other investments - net	48,537	47,339
Total investments held, continuing operations	2,203,514	2,217,603
Assets held for sale - net	1,020	1,020
Total investments	2,204,534	2,218,623
Cash and cash equivalents	25,611	1,711
Restricted cash	6,675	7,078
Accounts receivable - net	122,435	118,473
Investment in affiliates	159,319	163,610
Other assets	54,004	38,224
Total assets	2,572,578	2,547,719
LIABILITIES AND STOCKHOLDERS' EQUITY
Revolving line of credit	200,000	258,000
Secured borrowings
Unsecured borrowings - net	1,179,258	1,179,345
Accrued expenses and other liabilities	87,566	99,045
Intercompany payable
Total liabilities	1,466,824	1,536,390
Stockholders' equity:
Common stock	11,615	11,239
Common stock - additional paid-in capital	1,771,374	1,664,855
Cumulative net earnings	792,248	754,128
Cumulative dividends paid	(1,469,483)	(1,418,893)
Total stockholders' equity	1,105,754	1,011,329
Total liabilities and stockholders' equity	2,572,578	2,547,719
Non-guarantor subsidiaries
Real estate properties
Land and buildings	571,611	571,687
Less accumulated depreciation	(51,534)	(45,150)
Real estate properties - net	520,077	526,537
Mortgage notes receivable - net
Real estate properties, total	520,077	526,537
Other investments - net
Total investments held, continuing operations	520,077	526,537
Assets held for sale - net
Total investments	520,077	526,537
Cash and cash equivalents
Restricted cash	27,702	29,582
Accounts receivable - net	7,823	6,707
Investment in affiliates
Other assets	35,780	35,070
Total assets	591,382	597,896
LIABILITIES AND STOCKHOLDERS' EQUITY
Revolving line of credit
Secured borrowings	365,428	366,538
Unsecured borrowings - net	21,008	21,049
Accrued expenses and other liabilities	45,627	46,699
Intercompany payable	134,788	143,158
Total liabilities	566,851	577,444
Stockholders' equity:
Common stock
Common stock - additional paid-in capital
Cumulative net earnings	24,531	20,452
Cumulative dividends paid
Total stockholders' equity	24,531	20,452
Total liabilities and stockholders' equity	591,382	597,896
Elimination Company
Real estate properties
Land and buildings
Less accumulated depreciation
Real estate properties - net
Mortgage notes receivable - net
Real estate properties, total
Other investments - net
Total investments held, continuing operations
Assets held for sale - net
Total investments
Cash and cash equivalents
Restricted cash
Accounts receivable - net
Investment in affiliates	(159,319)	(163,610)
Other assets
Total assets	(159,319)	(163,610)
LIABILITIES AND STOCKHOLDERS' EQUITY
Revolving line of credit
Secured borrowings
Unsecured borrowings - net
Accrued expenses and other liabilities
Intercompany payable	(134,788)	(143,158)
Total liabilities	(134,788)	(143,158)
Stockholders' equity:
Common stock
Common stock - additional paid-in capital
Cumulative net earnings	(24,531)	(20,452)
Cumulative dividends paid
Total stockholders' equity	(24,531)	(20,452)
Total liabilities and stockholders' equity	$ (159,319)	$ (163,610)

XML

CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Parentheticals) (USD $) In Thousands, except Per Share data, unless otherwise specified	3 Months Ended
	Mar. 31, 2013
Balance (in shares)	112,393
Dividend reinvestment and stock purchase plan, shares	1,315
Dividend reinvestment plan (in dollars per share)	$ 27.63
Equity Shelf Program (in shares)	2,440
Equity Shelf Program, (in dollars per share)	$ 28.95
Common dividends, (in dollars per share)	$ 0.45
Balance (in shares)	116,153
Directors
Grant of restricted stock (in shares)	4
Grant of restricted stock (in dollars per share)	$ 26.42
Grant of stock as payment of directors fees (in shares)	1
Grant of stock as payment of directors fees (in dollars per share)	$ 27.75

XML

TAXES (Narrative) (Detail) (USD $) In Millions, unless otherwise specified	Mar. 31, 2013
Investments, Owned, Federal Income Tax Note [Line Items]
Permitted ownership of a taxable REIT subsidiary ("TRS"), maximum percentage	100.00%
Net operating loss carry-forward	$ 1.1

XML

PROPERTIES AND INVESTMENTS (Tables)

3 Months Ended

Mar. 31, 2013

Real Estate [Abstract]

Schedule of unaudited pro forma results of business acquisition

The following pro forma information is not indicative of future operations.

	Pro Forma
	Three Months Ended
	March 31,
	2013		2012
	(in thousands, except per share amounts, unaudited)
Revenues	$	101,761	$	98,021
Net income available to common stockholders		38,120		31,690
Earnings per share – diluted:
Net income available to common stockholders – as reported	$	0.34	$	0.25
Net income available to common stockholders – pro forma		0.34		0.30

XML

STOCK-BASED COMPENSATION (Detail 1) (USD $) In Thousands, unless otherwise specified	3 Months Ended
	Mar. 31, 2013	Mar. 31, 2012
Disclosure Of Compensation Related Costs, Share-Based Payments [Abstract]
Stock-based compensation expense	$ 1,452	$ 1,485

XML

FINANCING ACTIVITIES AND BORROWING ARRANGEMENTS (Tables)

3 Months Ended

Mar. 31, 2013

Debt Disclosure [Abstract]

Schedule of long-term borrowings

The following is a summary of our long-term borrowings:

	Maturity	Current Rate			March 31, 2013		December 31, 2012
					(in thousands)
Secured borrowings:
HUD Berkadia mortgages assumed June 2010 (1)	2036 - 2040		6.61	%	$	62,515	$	62,921
HUD Capital Funding mortgages assumed June 2010 (1)	2040 - 2045		4.85	%		130,332		130,887
HUD mortgages assumed October 2011 (1)	2036 - 2040		4.87	%		31,782		31,991
HUD mortgages assumed December 2011(1)	2044		3.06	%		59,355		58,884
HUD mortgages assumed December 2012(1)	2031 - 2045		5.50	%		81,444		81,855
Total secured borrowings						365,428		366,538
Unsecured borrowings:
Revolving line of credit	2016		-		$	—	$	158,000
Term Loan	2017		1.95	%		200,000		100,000
						200,000		258,000
2020 Notes	2020		7.50	%		200,000		200,000
2022 Notes	2022		6.75	%		575,000		575,000
2024 Notes	2024		5.875	%		400,000		400,000
Subordinated debt	2021		9.00	%		21,008		21,049
						1,196,008		1,196,049
Premium - net						4,258		4,345
Total unsecured borrowings						1,400,266		1,458,394
Totals – net					$	1,765,694	$	1,824,932

(1) Reflects the weighted average annual interest rate on the mortgages.

XML

CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $) In Thousands, unless otherwise specified	3 Months Ended
	Mar. 31, 2013	Mar. 31, 2012
Cash flows from operating activities
Net income	$ 38,120	$ 26,084
Adjustment to reconcile net income to cash provided by operating activities:
Depreciation and amortization	31,959	27,147
Impairment on real estate properties		272
Amortization of deferred financing and debt extinguishment costs	682	7,737
Restricted stock amortization expense	1,452	1,485
Gain on assets sold - net		(5,316)
Amortization of acquired in-place leases - net	(1,304)	(1,426)
Other		(38)
Change in operating assets and liabilities - net of amounts assumed/acquired:
Accounts receivable, net	635	176
Straight-line rent	(6,010)	(6,541)
Lease inducement	842	842
Effective yield receivable on mortgage notes	(545)	(554)
Other operating assets and liabilities	(8,231)	(324)
Net cash provided by operating activities	57,600	49,544
Cash flows from investing activities
Acquisition of real estate - net of liabilities assumed and escrows acquired		(1,852)
Placement of mortgage loans	(2,049)	(1,309)
Proceeds from sale of real estate investments		14,068
Capital improvements and funding of other investments	(8,328)	(7,985)
Proceeds from other investments	1,770	8,060
Investments in other investments	(2,968)	(1,069)
Collection of mortgage principal	119	119
Net cash (used in) provided by investing activities	(11,456)	10,032
Cash flows from financing activities
Proceeds from credit facility borrowings	155,000	45,000
Payments on credit facility borrowings	(213,000)	(290,500)
Receipts of other long-term borrowings	59,355	400,000
Payments of other long-term borrowings	(59,997)	(176,007)
Payments of financing related costs	(806)	(12,517)
Receipts from dividend reinvestment plan	36,330	14,224
Net proceeds from issuance of common stock	51,453	5,170
Dividends paid	(50,579)	(42,580)
Net cash used in financing activities	(22,244)	(57,210)
Increase in cash and cash equivalents	23,900	2,366
Cash and cash equivalents at beginning of period	1,711	351
Cash and cash equivalents at end of period	25,611	2,717
Interest paid during the period, net of amounts capitalized	26,092	22,163
Non-cash financing activities:
Common stock subscription	$ 17,639

XML

CONSOLIDATED BALANCE SHEETS (Parentheticals) (USD $) In Thousands, except Per Share data, unless otherwise specified	Mar. 31, 2013	Dec. 31, 2012
Statement Of Financial Position [Abstract]
Common stock, par value (in dollars per share)	$ 0.10	$ 0.10
Common stock, shares authorized	200,000	200,000
Common stock, shares issued	116,153	112,393
Common stock, shares outstanding	116,153	112,393

XML

EARNINGS PER SHARE

3 Months Ended

Mar. 31, 2013

Net Income Available To Common Per Share

EARNINGS PER SHARE

NOTE 10 – EARNINGS PER SHARE

The computation of basic earnings per share (“EPS”) is computed by dividing net income available to common stockholders by the weighted-average number of shares of common stock outstanding during the relevant period.  Diluted EPS is computed using the treasury stock method, which is net income available to common stockholders divided by the total weighted-average number of common outstanding shares plus the effect of dilutive common equivalent shares during the respective period.  Dilutive common shares reflect the assumed issuance of additional common shares pursuant to certain of our share-based compensation plans, including stock options, restricted stock and performance restricted stock units.

The following tables set forth the computation of basic and diluted earnings per share:

	Three Months Ended March 31,
	2013		2012
	(in thousands, except per share amounts)
Numerator:
Net income	$	38,120	$	26,084
Numerator for net income available to common per share - basic and diluted	$	38,120	$	26,084
Denominator:
Denominator for basic earnings per share		112,782		103,754
Effect of dilutive securities:
Restricted stock		714		241
Deferred stock		26		17
Denominator for diluted earnings per share		113,522		104,012
Earnings per share – basic:
Net income – basic	$	0.34	$	0.25
Earnings per share – diluted:
Net income – diluted	$	0.34	$	0.25

XML

Document and Entity Information	3 Months Ended
	Mar. 31, 2013	May 03, 2013
Document and Entity Information [Abstract]
Entity Registrant Name	OMEGA HEALTHCARE INVESTORS INC
Entity Central Index Key	0000888491
Trading Symbol	ohi
Entity Current Reporting Status	Yes
Entity Voluntary Filers	No
Current Fiscal Year End Date	--12-31
Entity Filer Category	Large Accelerated Filer
Entity Common Stock Shares Outstanding		116,154,455
Document Type	10-Q
Document Period End Date	Mar. 31, 2013
Amendment Flag	false
Document Fiscal Year Focus	2013
Document Fiscal Period Focus	Q1

XML

CONSOLIDATING FINANCIAL STATEMENTS

3 Months Ended

Mar. 31, 2013

Condensed Financial Information Of Parent Company Only Disclosure [Abstract]

CONSOLIDATING FINANCIAL STATEMENTS

NOTE 11 – CONSOLIDATING FINANCIAL STATEMENTS
 

As of March 31, 2013, we had outstanding (i) $200 million 7.5% Senior Notes due 2020, (ii) $575 million 6.75% Senior Notes due 2022 and (iii) $400 million 5.875% Senior Notes due 2024, which we collectively refer to as the Senior Notes.  The Senior Notes are fully and unconditionally guaranteed, jointly and severally, by each of our subsidiaries that guarantee other indebtedness of Omega or any of the subsidiary guarantors.  Any subsidiary that we properly designate as an “unrestricted subsidiary” under the indentures governing the Senior Notes will not provide guarantees of the Senior Notes.  As of and prior to March 31, 2010, the non-subsidiary guarantors were minor and insignificant.  On June 29, 2010, we designated as “unrestricted subsidiaries” the 39 subsidiaries we acquired from CapitalSource subject to HUD indebtedness.  During the fourth quarter of 2011, we designated as “unrestricted subsidiaries” 20 subsidiaries we acquired subject to HUD indebtedness, of which five subsidiaries were removed in July 2012 due to the retirement of the HUD related mortgages.  During the fourth quarter of 2012, we designated as “unrestricted subsidiaries” eight subsidiaries we acquired subject to HUD indebtedness.
 

For the three months ended March 31, 2013 and 2012, the operating cash flow of the non-guarantor subsidiaries approximated net income of the non-guarantor subsidiaries, adjusted for depreciation and amortization expense.  On March 26, 2013, the non-guarantor subsidiaries refinanced existing HUD mortgage debt on 12 properties in Arkansas for approximately $59.4 million. The refinanced amount included $58.9 million related to retiring the old HUD debt and $0.5 million of closing costs that were added to the new (refinanced) HUD debt.  In addition, the non-guarantor subsidiaries also made $1.1 million of routine principal payments during the three months ended March 31, 2013.  For the three-month period ended March 31, 2013, the non-guarantor subsidiaries have not engaged in investing or financing activities other than the refinancing activity and routine principal payments.  For the three-month period ended March 31, 2012, the non-guarantor subsidiaries have not engaged in investing or financing activities other than the principal payment of $1.0 million for the HUD mortgages on the facilities owned by the non-guarantor subsidiaries.  All of the subsidiary and non-subsidiary guarantors of our outstanding senior notes are 100% owned by Omega.
 

The following summarized condensed consolidating financial information segregates the financial information of the non-guarantor subsidiaries from the financial information of Omega Healthcare Investors, Inc. and the subsidiary guarantors under the Senior Notes.  The results and financial position of acquired entities are included from the dates of their respective acquisitions.

OMEGA HEALTHCARE INVESTORS, INC.

CONSOLIDATING BALANCE SHEETS

Unaudited

(in thousands, except per share amounts)
 

	March 31, 2013
	Issuer & Subsidiary Guarantors			Non-Guarantor Subsidiaries			Elimination Company			Consolidated
Real estate properties
Land and buildings	$	2,475,194		$	571,611		$	—		$	3,046,805
Less accumulated depreciation		(560,768	)		(51,534	)		—			(612,302	)
Real estate properties – net		1,914,426			520,077			—			2,434,503
Mortgage notes receivable – net		240,551			—			—			240,551
		2,154,977			520,077			—			2,675,054
Other investments – net		48,537			—			—			48,537
		2,203,514			520,077			—			2,723,591
Assets held for sale – net		1,020			—			—			1,020
Total investments		2,204,534			520,077			—			2,724,611
Cash and cash equivalents		25,611			—			—			25,611
Restricted cash		6,675			27,702			—			34,377
Accounts receivable – net		122,435			7,823			—			130,258
Investment in affiliates		159,319			—			(159,319	)		—
Other assets		54,004			35,780			—			89,784
Total assets	$	2,572,578		$	591,382		$	(159,319	)	$	3,004,641
LIABILITIES AND STOCKHOLDERS’ EQUITY
Revolving line of credit	$	200,000		$	—		$	—		$	200,000
Secured borrowings		—			365,428			—			365,428
Unsecured borrowings – net		1,179,258			21,008			—			1,200,266
Accrued expenses and other liabilities		87,566			45,627			—			133,193
Intercompany payable		—			134,788			(134,788	)		—
Total liabilities		1,466,824			566,851		$	(134,788	)	$	1,898,887
Stockholders’ equity:
Common stock		11,615			—			—			11,615
Common stock – additional paid-in-capital		1,771,374			—			—			1,771,374
Cumulative net earnings		792,248			24,531			(24,531	)		792,248
Cumulative dividends paid		(1,469,483	)		—			—			(1,469,483	)
Total stockholders’ equity		1,105,754			24,531		$	(24,531	)		1,105,754
Total liabilities and stockholders’ equity	$	2,572,578		$	591,382		$	(159,319	)		3,004,641

OMEGA HEALTHCARE INVESTORS, INC.

CONSOLIDATING BALANCE SHEETS

 (in thousands, except per share amounts)
 

	December 31, 2012
	Issuer & Subsidiary Guarantors			Non – Guarantor Subsidiaries			Elimination Company			Consolidated
ASSETS
Real estate properties
Land and buildings	$	2,466,866		$	571,687		$	—		$	3,038,553
Less accumulated depreciation		(535,223	)		(45,150	)		—			(580,373	)
Real estate properties – net		1,931,643			526,537			—			2,458,180
Mortgage notes receivable – net		238,621			—			—			238,621
		2,170,264			526,537			—			2,696,801
Other investments – net		47,339			—			—			47,339
		2,217,603			526,537			—			2,744,140
Assets held for sale – net		1,020			—			—			1,020
Total investments		2,218,623			526,537			—			2,745,160
Cash and cash equivalents		1,711			—			—			1,711
Restricted cash		7,078			29,582			—			36,660
Accounts receivable – net		118,473			6,707			—			125,180
Investment in affiliates		163,610			—			(163,610	)		—
Other assets		38,224			35,070			—			73,294
Total assets	$	2,547,719		$	597,896			(163,610	)	$	2,982,005
LIABILITIES AND STOCKHOLDERS’ EQUITY
Revolving line of credit	$	258,000		$	—		$	—		$	258,000
Secured borrowings		—			366,538			—			366,538
Unsecured borrowings – net		1,179,345			21,049			—			1,200,394
Accrued expenses and other liabilities		99,045			46,699			—			145,744
Intercompany payable		—			143,158			(143,158	)		—
Total liabilities		1,536,390			577,444			(143,158	)		1,970,676
Stockholders’ equity:
Common stock		11,239			—			—			11,239
Common stock – additional paid-in-capital		1,664,855			—			—			1,664,855
Cumulative net earnings		754,128			20,452			(20,452	)		754,128
Cumulative dividends paid		(1,418,893	)		—			—			(1,418,893	)
Total stockholders’ equity		1,011,329			20,452			(20,452	)		1,011,329
Total liabilities and stockholders’ equity	$	2,547,719		$	597,896		$	(163,610	)	$	2,982,005

OMEGA HEALTHCARE INVESTORS, INC.

CONSOLIDATING STATEMENTS OF OPERATIONS

Unaudited

(in thousands, except per share amounts)

	Three Months Ended March 31, 2013
	Issuer & Subsidiary Guarantors			Non – Guarantor Subsidiaries			Elimination Company			Consolidated
Revenue
Rental income	$	77,641		$	15,468		$	-		$	93,109
Mortgage interest income		7,346			-			-			7,346
Other investment income – net		1,306			-			-			1,306
Total operating revenues		86,293			15,468			-			101,761
Expenses
Depreciation and amortization		25,575			6,384			-			31,959
General and administrative		5,082			115			-			5,197
Acquisition costs		134			-			-			134
Total operating expenses		30,791			6,499			-			37,290
Income before other income and expense		55,502			8,969			-			64,471
Other income (expense):
Interest income		(5	)		8			-			3
Interest expense		(20,774	)		(4,898	)		-			(25,672	)
Interest – amortization of deferred financing costs		(682	)		-			-			(682	)
Equity in earnings		4,079			-			(4,079	)		-
Total other expense		(17,382	)		(4,890	)		(4,079	)		(26,351	)
Net income available to common stockholders	$	38,120		$	4,079		$	(4,079	)	$	38,120

OMEGA HEALTHCARE INVESTORS, INC.

CONSOLIDATING STATEMENTS OF OPERATIONS

Unaudited

(in thousands, except per share amounts)

	Three Months Ended March 31, 2012
	Issuer & Subsidiary Guarantors			Non – Guarantor Subsidiaries			Elimination Company			Consolidated
Revenue
Rental income	$	63,964		$	12,011		$	-		$	75,975
Mortgage interest income		7,336			-			-			7,336
Other investment income – net		1,130			-			-			1,130
Miscellaneous		74			-			-			74
Total operating revenues		72,504			12,011			-			84,515
Expenses
Depreciation and amortization		21,899			5,248			-			27,147
General and administrative		5,414			112			-			5,526
Acquisition costs		105			-			-			105
Impairment loss on real estate properties		272			-			-			272
Total operating expenses		27,690			5,360			-			33,050
Income before other income and expense		44,814			6,651			-			51,465
Other income (expense):
Interest income		-			7			-			7
Interest expense		(19,107	)		(3,860	)		-			(22,967	)
Interest – amortization of deferred financing costs		(629	)		-			-			(629	)
Interest – refinancing costs		(7,108	)		-			-			(7,108	)
Equity in earnings		2,798			-			(2,798	)		-
Total other expense		(24,046	)		(3,853	)		(2,798	)		(30,697	)
Income before gain on assets sold		20,768			2,798			(2,798	)		20,768
Gain on assets sold – net		5,316			-			-			5,316
Net income available to common stockholders	$	26,084		$	2,798		$	(2,798	)	$	26,084

XML

CONSOLIDATED STATEMENTS OF OPERATIONS (USD $) In Thousands, except Per Share data, unless otherwise specified	3 Months Ended
	Mar. 31, 2013	Mar. 31, 2012
Revenue
Rental income	$ 93,109	$ 75,975
Mortgage interest income	7,346	7,336
Other investment income - net	1,306	1,130
Miscellaneous		74
Total operating revenues	101,761	84,515
Expenses
Depreciation and amortization	31,959	27,147
General and administrative	5,197	5,526
Acquisition costs	134	105
Impairment loss on real estate properties		272
Total operating expenses	37,290	33,050
Income before other income and expense	64,471	51,465
Other income (expense)
Interest income	3	7
Interest expense	(25,672)	(22,967)
Interest - amortization of deferred financing costs	(682)	(629)
Interest - refinancing costs		(7,108)
Total other expense	(26,351)	(30,697)
Income before gain on assets sold	38,120	20,768
Gain on assets sold - net		5,316
Net income available to common stockholders	$ 38,120	$ 26,084
Basic:
Net income	$ 0.34	$ 0.25
Diluted:
Net income	$ 0.34	$ 0.25
Dividends declared and paid per common share	$ 0.45	$ 0.41
Weighted-average shares outstanding, basic	112,782	103,754
Weighted-average shares outstanding, diluted	113,522	104,012

XML

TAXES

3 Months Ended

Mar. 31, 2013

Income Tax Disclosure [Abstract]

TAXES

NOTE 5 – TAXES

So long as we qualify as a real estate investment trust (“REIT”) under the Internal Revenue Code (the “Code”), we generally will not be subject to federal income taxes on the REIT taxable income that we distribute to stockholders, subject to certain exceptions.  On a quarterly and annual basis, we test our compliance within the REIT taxation rules to ensure that we were in compliance with the rules.

Subject to the limitation under the REIT asset test rules, we are permitted to own up to 100% of the stock of one or more taxable REIT subsidiaries (“TRSs”).  Currently, we have one TRS that is taxable as a corporation and that pays federal, state and local income tax on its net income at the applicable corporate rates.  As of March 31, 2013, the TRS had a net operating loss carry-forward of $1.1 million.  The loss carry-forward is fully reserved with a valuation allowance as of March 31, 2013.

XML

DIVIDENDS

3 Months Ended

Mar. 31, 2013

Dividends [Abstract]

DIVIDENDS

NOTE 4 – DIVIDENDS

Common Dividends

On April 16, 2013, the Board of Directors declared a common stock dividend of $0.46 per share, increasing the quarterly common dividend by $0.01 per share over the prior quarter, to be paid May 15, 2013 to common stockholders of record on April 30, 2013.

On January 16, 2013, the Board of Directors declared a common stock dividend of $0.45 per share, increasing the quarterly common dividend by $0.01 per share over the prior quarter, which was paid February 15, 2013 to common stockholders of record on January 31, 2013.

XML

STOCK-BASED COMPENSATION (Tables)

3 Months Ended

Mar. 31, 2013

Disclosure Of Compensation Related Costs, Share-Based Payments [Abstract]

Schedule of stock-based compensation expense

The following is a summary of our stock-based compensation expense for the three- month periods ended March 31, 2013 and 2012, respectively:

	Three Months Ended March 31,
	2013		2012
	(in thousands)
Stock-based compensation expense	$	1,452	$	1,485

Schedule of unrecognized compensation cost associated with outstanding restricted stock and PRSU awards

The following table summarizes our total unrecognized compensation cost as of March 31, 2013 associated with outstanding restricted stock and PRSU awards to employees:

	Shares/ Units		Grant Date Average Fair Value Per Unit/ Share		Total Compensation Cost (in millions)		Weighted Average Period of Expense Recognition (in months)		Unrecognized Compensation Cost (in millions)
Restricted stock		428,503	$	22.44	$	9.6		36	$	2.4
2013 Annual PRSUs		124,244	$	8.92		1.1		12		0.8
Multi-year absolute TSR PRSUs		279,550	$	11.06		3.1		44		1.1
Multi-year relative TSR PRSUs		93,183	$	12.26		1.1		44		0.4
Total		925,480	$	14.93	$	14.9			$	4.7

XML

SUBSEQUENT EVENTS

3 Months Ended

Mar. 31, 2013

Subsequent Events [Abstract]

SUBSEQUENT EVENTS

NOTE 12 – SUBSEQUENT EVENTS

$25 Million Mezzanine Loan

In May 2013, we invested in a $24.7 million mezzanine loan with a third party.  The loan bears interest at 12% per annum and matures in December 2017.

HUD Loans Payoff

During the second quarter of 2013, we notified Berkadia of our intent to retire the HUD Berkadia mortgages.  We anticipate using approximately $51.1 million in funds borrowed from our 2012 Credit Facility to repay the contractual portion of the HUD Berkadia Mortgages.  We also anticipate accelerating the amortization of the $11.4 million of premium associated with the HUD Berkadia mortgages.

XML

FINANCIAL INSTRUMENTS

3 Months Ended

Mar. 31, 2013

Fair Value Disclosures [Abstract]

FINANCIAL INSTRUMENTS

NOTE 8 – FINANCIAL INSTRUMENTS

At March 31, 2013 and December 31, 2012, the carrying amounts and fair values of our financial instruments were as follows:

	March 31, 2013				December 31, 2012
	Carrying Amount		Fair Value		Carrying Amount		Fair Value
Assets:	(in thousands)
Cash and cash equivalents	$	25,611	$	25,611	$	1,711	$	1,711
Restricted cash		34,377		34,377		36,660		36,660
Mortgage notes receivable – net		240,551		238,145		238,621		235,705
Other investments – net		48,537		45,427		47,339		44,077
Totals	$	349,076	$	343,560	$	324,331	$	318,153
Liabilities:
Revolving line of credit	$	—	$	—	$	158,000	$	158,000
Term loan		200,000		200,000		100,000		100,000
7.50% Notes due 2020 – net		197,632		253,145		197,546		252,363
6.75% Notes due 2022 – net		581,626		732,702		581,799		724,240
5.875% Notes due 2024 – net		400,000		437,027		400,000		441,761
HUD debt		365,428		412,821		366,538		433,803
Subordinated debt		21,008		27,771		21,049		27,896
Totals	$	1,765,694	$	2,063,466	$	1,824,932	$	2,138,063

Fair value estimates are subjective in nature and are dependent on a number of important assumptions, including estimates of future cash flows, risks, discount rates and relevant comparable market information associated with each financial instrument (see Note 2 – Summary of Significant Accounting Policies in our 2012 Annual Report on Form 10-K).  The use of different market assumptions and estimation methodologies may have a material effect on the reported estimated fair value amounts.

The following methods and assumptions were used in estimating fair value disclosures for financial instruments.

● Cash and cash equivalents and restricted cash:  The carrying amount of cash and cash equivalents and restricted cash reported in the balance sheet approximates fair value because of the short maturity of these instruments (i.e., less than 90 days).

● Mortgage notes receivable:  The fair values of the mortgage notes receivables are estimated using a discounted cash flow analysis, using interest rates being offered for similar loans to borrowers with similar credit ratings (Level 3).

● Other investments:  Other investments are primarily comprised of: (i) notes receivable and (ii) an investment in redeemable non-convertible preferred security of an unconsolidated business accounted for using the cost method of accounting.  The fair values of notes receivable are estimated using a discounted cash flow analysis, using interest rates being offered for similar loans to borrowers with similar credit ratings (Level 3).  The fair value of the investment in the unconsolidated business is estimated using quoted market value and considers the terms of the underlying arrangement (Level 3).

● Revolving line of credit:  The fair value of our borrowings under variable rate agreements are estimated using an expected present value technique based on expected cash flows discounted using the current market rates (Level 2).

● Senior notes and other long-term borrowings:  The fair value of our borrowings under fixed rate agreements are estimated based on open market trading activity provided by a third party (Level 2).

XML

STOCK-BASED COMPENSATION

3 Months Ended

Mar. 31, 2013

Disclosure Of Compensation Related Costs, Share-Based Payments [Abstract]

STOCK-BASED COMPENSATION

NOTE 6 – STOCK-BASED COMPENSATION

The following is a summary of our stock-based compensation expense for the three- month periods ended March 31, 2013 and 2012, respectively:

	Three Months Ended March 31,
	2013		2012
	(in thousands)
Stock-based compensation expense	$	1,452	$	1,485

Stock Awards

Effective January 2011, we granted 428,503 shares of restricted stock and 496,977 performance restricted stock units (“PRSUs”) to six employees.In each of January 2012 and 2013, we granted an additional 124,244 PRSUs to six employees.

Restricted Stock Awards

The restricted stock awards vest 100% on December 31, 2013, subject to continued employment on the vesting date and subject to certain exceptions for certain qualifying terminations of employment or a change in control of the Company.  As of March 31, 2013, no shares of restricted stock have vested under these restricted stock awards.

Performance Restricted Stock Units

Effective January 1, 2011, we awarded three types of PRSUs to the six employees: (i) 124,244 annual total shareholder return (“TSR”) PRSUs for the year ended December 31, 2011 (“2011 Annual TSR PRSUs”); (ii) 279,550 multi-year absolute TSR PRSUs and (iii) 93,183 multi-year relative TSR PRSUs.  On January 1, 2012 and 2013, we awarded to the six employees 124,244 annual TSR PRSUs for the year ended December 31, 2012 and 2013 (the “2012 Annual TSR PRSUs” and the “2013 Annual TSR PRSUs”).

Annual TSR PRSUs

The number of shares earned under the annual TSR PRSUs depends generally on the level of achievement of TSR for the year.  The annual TSR PRSUs vest on December 31 of the year, subject to continued employment on the vesting date and subject to certain exceptions for certain qualifying terminations of employment or a change in control of the Company.  The 2011 Annual TSR PRSUs were forfeited because the required TSR for 2011 was not achieved.  The performance requirement for the 2012 Annual TSR PRSUs was achieved and the 124,244 shares vested and were distributed to the employees at December 31, 2012.  As of March 31, 2013, the 2013 annual TSR PRSUs have not been earned.

Multi-year Absolute TSR PRSUs

The number of shares earned under the multi-year absolute TSR PRSUs depends generally on the level of achievement of TSR for the three-years ending December 31, 2013.  The multi-year absolute TSR PRSUs vest 25% on the last day of each calendar quarter in 2014, subject to continued employment on the vesting date and subject to certain exceptions for certain qualifying terminations of employment or a change in control of the Company.

Multi-year Relative TSR PRSUs

The number of shares earned under the multi-year relative TSR PRSUs depends generally on the level of achievement of TSR relative to other real estate investment trusts in the MSCI U.S. REIT Index for the three-years ending December 31, 2013.  The multi-year relative TSR PRSUs vest 25% on the last day of each calendar quarter in 2014, subject to continued employment on the vesting date and subject to certain exceptions for certain qualifying terminations of employment or a change in control of the Company.

The PRSU awards have varying degrees of performance requirements to achieve vesting, and each PRSU award represents the right to a variable number of shares of common stock and related dividend equivalents based on dividends paid to stockholders during the applicable performance period.

As of March 31, 2013, none of the PRSUs are vested or earned.

The following table summarizes our total unrecognized compensation cost as of March 31, 2013 associated with outstanding restricted stock and PRSU awards to employees:

	Shares/  Units		Grant Date Average Fair  Value Per  Unit/ Share		Total Compensation Cost (in millions)		Weighted  Average Period of  Expense Recognition  (in months)		Unrecognized Compensation Cost (in millions)
Restricted stock		428,503	$	22.44	$	9.6		36	$	2.4
2013 Annual PRSUs		124,244	$	8.92		1.1		12		0.8
Multi-year absolute TSR PRSUs		279,550	$	11.06		3.1		44		1.1
Multi-year relative TSR PRSUs		93,183	$	12.26		1.1		44		0.4
Total		925,480	$	14.93	$	14.9			$	4.7

We used a Monte Carlo model to estimate the fair value for PRSUs granted to the employees.

Director Restricted Stock Grants

As of March 31, 2013, we had 21,957 shares of restricted stock outstanding to directors.  The directors’ restricted shares are scheduled to vest over the next three years.  As of March 31, 2013, the unrecognized compensation cost associated with outstanding director restricted stock grants is approximately $0.3 million.

XML

FINANCING ACTIVITIES AND BORROWING ARRANGEMENTS

3 Months Ended

Mar. 31, 2013

Debt Disclosure [Abstract]

FINANCING ACTIVITIES AND BORROWING ARRANGEMENTS

NOTE 7 – FINANCING ACTIVITIES AND BORROWING ARRANGEMENTS

Secured and Unsecured Borrowings

The following is a summary of our long-term borrowings:

	Maturity	Current Rate			March 31, 2013		December 31, 2012
					(in thousands)
Secured borrowings:
HUD Berkadia mortgages assumed June 2010 (1)	2036 - 2040		6.61	%	$	62,515	$	62,921
HUD Capital Funding mortgages assumed June 2010 (1)	2040 - 2045		4.85	%		130,332		130,887
HUD mortgages assumed October 2011 (1)	2036 - 2040		4.87	%		31,782		31,991
HUD mortgages assumed December 2011(1)	2044		3.06	%		59,355		58,884
HUD mortgages assumed December 2012(1)	2031 - 2045		5.50	%		81,444		81,855
Total secured borrowings						365,428		366,538
Unsecured borrowings:
Revolving line of credit	2016		-		$	—	$	158,000
Term Loan	2017		1.95	%		200,000		100,000
						200,000		258,000
2020 Notes	2020		7.50	%		200,000		200,000
2022 Notes	2022		6.75	%		575,000		575,000
2024 Notes	2024		5.875	%		400,000		400,000
Subordinated debt	2021		9.00	%		21,008		21,049
						1,196,008		1,196,049
Premium - net						4,258		4,345
Total unsecured borrowings						1,400,266		1,458,394
Totals – net					$	1,765,694	$	1,824,932

(1) Reflects the weighted average annual interest rate on the mortgages.

Certain of our other secured and unsecured borrowings are subject to customary affirmative and negative covenants, including financial covenants.  As of December 31, 2012 and March 31, 2013, we were in compliance with all affirmative and negative covenants, including financial covenants, for our secured and unsecured borrowings.

Bank Credit Agreements

We have a $700 million unsecured credit facility that we entered into on December 6, 2012, comprised of a $500 million unsecured revolving credit facility  (the “2012 Revolving Credit Facility”) and a $200 million unsecured, deferred draw term loan facility (the “2012 Term Loan Facility” and, together with the 2012 Revolving Credit Facility, collectively, the “2012 Credit Facilities”).

The 2012 Credit Facilities include an “accordion feature” that permits us to expand its borrowing capacity by a combined $300 million, to a total of $1 billion.

At March 31, 2013, we had no borrowings and no letters of credit outstanding under the 2012 Revolving Credit Facility.  The 2012 Revolving Credit Facility matures on December 6, 2016, with an option by us to extend the maturity one additional year.  The 2012 Revolving Credit Facility is priced at LIBOR plus an applicable percentage (beginning at 150 basis points, with a range of 100 to 190 basis points) based on our ratings from Standard & Poor’s, Moody’s and/or Fitch Ratings, plus a facility fee based on the same ratings (initially 30 basis points, with a range of 15 to 45 basis points).

At March 31, 2013, the full $200 million was outstanding under the 2012 Term Loan Facility.  The 2012 Term Loan Facility is also priced at LIBOR plus an applicable percentage (beginning at 175 basis points, with a range of 110 to 230 basis points) based our ratings from Standard & Poor’s, Moody’s and/or Fitch Ratings.  The 2012 Term Loan Facility matures on December 6, 2017.

HUD Mortgage Debt Refinancing

On March 26, 2013, we refinanced existing HUD mortgage debt on 12 properties in Arkansas for approximately $59.4 million including closing costs that were added to the outstanding balance.  The annual interest rate for the refinanced debt decreased from 5.55% to approximately 3.06%, with the term of the refinanced mortgages remaining unchanged.  For the three months ended March 31, 2013, we paid off a total of $58.9 million, including routine principal payments on the 12 Arkansas mortgage debts.

$250 Million Equity Shelf Program

On March 18, 2013, we entered into separate Equity Distribution Agreements (collectively, the “2013 Agreements”) to sell shares of our common stock having an aggregate gross sales price of up to $250 million (the “2013 ESP”) with several financial institutions, each as a sales agent and/or principal (collectively, the “Managers”).  Under the terms of the 2013 Agreements, we may sell shares of our common stock, from time to time, through or to the Managers having an aggregate gross sales price of up to $250 million.  Sales of the shares will be made by means of ordinary brokers’ transactions on the New York Stock Exchange at market prices, or as otherwise agreed with the applicable Manager.  We will pay each Manager compensation for sales of the shares equal to 2% of the gross sales price per share of shares sold through such Manager under the applicable 2013 Agreement.  We are not obligated to sell and the Managers are not obligated to buy or sell any shares under the 2013 Agreements.  No assurance can be given that we will sell any shares under the 2013 Agreements, or, if we do, as to the price or amount of shares that we sell, or the dates when such sales will take place.

For the three months ended March 31, 2013, we sold 1.5 million shares under the 2013 ESP, at an average price of $29.41 per share, generating gross proceeds of approximately $42.8 million, before $0.9 million of commissions.  Of the 1.5 million shares that we sold during the quarter, 0.6 million shares, representing gross proceeds of approximately $18.0 million had a settlement date in April 2013. We included net proceeds of $17.6 million as a receivable in other assets at March 31, 2013 with a corresponding increase in equity.

Termination of $245 Million Equity Shelf Program

On March 18, 2013, we terminated our $245 million Equity Shelf Program (the “2012 ESP”) that we entered into with several financial institutions on June 19, 2012.  For the three months ended March 31, 2013, we issued approximately 1.0 million shares under the 2012 ESP at an average price of $28.29 per share, generating gross proceeds of approximately $27.8 million, before $0.6 million commissions.

Since inception of the 2012 ESP, we have sold a total of 3.6 million shares of common stock generating total gross proceeds of $91.4 million under the program, before $1.9 million of commissions.  As a result of the termination of the 2012 ESP, no additional shares were issued under the 2012 ESP.

Dividend Reinvestment and Common Stock Purchase Plan

For the three-month period ended March 31, 2013, approximately 1.3 million shares of our common stock at an average price of $27.63 per share were issued through our Dividend Reinvestment and Common Stock Purchase Program for net proceeds of approximately $36.3 million.

XML

LITIGATION

3 Months Ended

Mar. 31, 2013

Commitments and Contingencies Disclosure [Abstract]

LITIGATION

NOTE 9 – LITIGATION

We are subject to various legal proceedings, claims and other actions arising out of the normal course of business. While any legal proceeding or claim has an element of uncertainty, management believes that the outcome of each lawsuit, claim or legal proceeding that is pending or threatened, or all of them combined, will not have a material adverse effect on our consolidated financial position or results of operations.

XML

DIVIDENDS (Narrative) (Detail) (USD $)	3 Months Ended		0 Months Ended
	Mar. 31, 2013	Mar. 31, 2012	Apr. 16, 2013 Subsequent Event
Dividends [Line Items]
Common stock dividend declared, per share	$ 0.45	$ 0.41	$ 0.46
Increase in quarterly common dividend, per share	$ 0.01		$ 0.01
Dividends declared, date of declaration	Jan. 16, 2013		Apr. 16, 2013
Dividends declared, date of payment	Feb. 15, 2013		May 15, 2013
Dividends declared, date of record	Jan. 31, 2013		Apr. 30, 2013

XML

BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES (Tables)

3 Months Ended

Mar. 31, 2013

Accounting Policies [Abstract]

Schedule of summary of net receivables

A summary of our net receivables by type is as follows:

	March 31, 2013			December 31, 2012
	(in thousands)
Contractual receivables	$	3,269		$	3,963
Effective yield interest receivables		4,121			3,576
Straight-line receivables		104,983			98,973
Lease inducements		18,465			19,307
Allowance		(580	)		(639	)
Accounts receivable – net	$	130,258		$	125,180

XML

EARNINGS PER SHARE (Tables)

3 Months Ended

Mar. 31, 2013

Net Income Available To Common Per Share

Schedule of computation of basic and diluted earnings per share

The following tables set forth the computation of basic and diluted earnings per share:

	Three Months Ended March 31,
	2013		2012
	(in thousands, except per share amounts)
Numerator:
Net income	$	38,120	$	26,084
Numerator for net income available to common per share - basic and diluted	$	38,120	$	26,084
Denominator:
Denominator for basic earnings per share		112,782		103,754
Effect of dilutive securities:
Restricted stock		714		241
Deferred stock		26		17
Denominator for diluted earnings per share		113,522		104,012
Earnings per share – basic:
Net income – basic	$	0.34	$	0.25
Earnings per share – diluted:
Net income – diluted	$	0.34	$	0.25

XML

FINANCING ACTIVITIES AND BORROWING ARRANGEMENTS - Long-term borrowings (Detail) - Unsecured Borrowings (Narrative) (Detail 1) (Unsecured borrowings, USD $)	3 Months Ended
	Mar. 31, 2013	Dec. 31, 2012	Dec. 06, 2012
Borrowing Arrangements [Line Items]
Credit facility, borrowing capacity			$ 700,000,000
2012 Revolving Credit Facility
Borrowing Arrangements [Line Items]
Revolving Line Of Credit	0	158,000,000
Credit facility, borrowing capacity			500,000,000
Pricing of credit facility at LIBOR plus an applicable percentage	1.50%
Credit facility, description of variable rate basis	The 2012 Revolving Credit Facility is priced at LIBOR plus an applicable percentage (beginning at 150 basis points, with a range of 100 to 190 basis points) based on our ratings from Standard & Poor's, Moody's and/or Fitch Ratings.
Facility fee, basis spread on variable rate	0.30%
Facility fee, description of variable rate basis	Facility fee based on the same ratings (initially 30 basis points, with a range of 15 to 45 basis points)
2012 Revolving Credit Facility | Minimum
Borrowing Arrangements [Line Items]
Pricing of credit facility at LIBOR plus an applicable percentage	1.00%
Facility fee, basis spread on variable rate	0.15%
2012 Revolving Credit Facility | Maximum
Borrowing Arrangements [Line Items]
Pricing of credit facility at LIBOR plus an applicable percentage	1.90%
Facility fee, basis spread on variable rate	0.45%
2012 Term Loan Facility
Borrowing Arrangements [Line Items]
Credit facility, borrowing capacity			200,000,000
Pricing of credit facility at LIBOR plus an applicable percentage	1.75%
Credit facility, description of variable rate basis	The 2012 Term Loan Facility is also priced at LIBOR plus an applicable percentage (beginning at 175 basis points, with a range of 110 to 230 basis points) based our ratings from Standard & Poor's, Moody's and/or Fitch Ratings.
2012 Term Loan Facility | Minimum
Borrowing Arrangements [Line Items]
Pricing of credit facility at LIBOR plus an applicable percentage	1.10%
2012 Term Loan Facility | Maximum
Borrowing Arrangements [Line Items]
Pricing of credit facility at LIBOR plus an applicable percentage	2.30%
2012 Credit Facilities
Borrowing Arrangements [Line Items]
Credit facility, potential borrowing capacity			300,000,000
2012 Credit Facilities | Maximum
Borrowing Arrangements [Line Items]
Credit facility, potential borrowing capacity			1,000,000,000
Term loan
Borrowing Arrangements [Line Items]
Term loan	$ 200,000,000	$ 100,000,000

XML

CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (USD $) In Thousands, unless otherwise specified	Common Stock Par Value	Common Stock Par Value Directors	Additional Paid-in Capital	Additional Paid-in Capital Directors	Cumulative Net Earnings	Cumulative Dividends	Total
Balance (112,393 common shares) at Dec. 31, 2012	$ 11,239		$ 1,664,855		$ 754,128	$ (1,418,893)	$ 1,011,329
Issuance of common stock:
Grant of restricted stock to company directors (4 shares at $26.42 per share)		1		(1)
Amortization of restricted stock			1,436				1,436
Dividend reinvestment plan (1,315 shares at $27.63 per share)	131		36,199				36,330
Grant of stock as payment of directors fees (1 share at an average of $27.75 per share)			37				37
Equity Shelf Program (2,440shares at $28.95 per share, net of issuance costs)	244		68,848				69,092
Net income					38,120		38,120
Common dividends ($0.45 per share)						(50,590)	(50,590)
Balance (116,153 common shares) at Mar. 31, 2013	$ 11,615		$ 1,771,374		$ 792,248	$ (1,469,483)	$ 1,105,754

XML

CONCENTRATION OF RISK

3 Months Ended

Mar. 31, 2013

Risks and Uncertainties [Abstract]

CONCENTRATION OF RISK

NOTE 3 – CONCENTRATION OF RISK

As of March 31, 2013, our portfolio of real estate investments consisted of 479 healthcare facilities, located in 34 states and operated by 46 third-party operators.  Our gross investment in these facilities, net of impairments and before reserve for uncollectible loans, totaled approximately $3.3 billion at March 31, 2013, with approximately 99% of our real estate investments related to long-term care facilities.  This portfolio is made up of 418 SNFs, 16 ALFs, 11 specialty facilities, fixed rate mortgages on 32 SNFs, and two SNFs that are held-for-sale.  At March 31, 2013, we also held miscellaneous investments of approximately $48.5 million, consisting primarily of secured loans to third-party operators of our facilities.

At March 31, 2013, we had investments with two operators and/or managers that exceeded 10% of our total investment: (i) Genesis Healthcare (“Genesis”) (11%), and (ii) CommuniCare Health Services, Inc. (“CommuniCare”) (10%).  The three states in which we had our highest concentration of investments were Florida (18%), Ohio (11%) and Indiana (10%) at March 31, 2013.

For the three-month period ended March 31, 2013, our revenues from operations totaled $101.8 million, of which approximately $13.8 million were from Genesis (14%) and $11.1 million from CommuniCare (11%).  No other operator generated more than 10% of our revenues from operations for the three-month period ended March 31, 2013.

XML

CONSOLIDATING FINANCIAL STATEMENTS (Tables)

3 Months Ended

Mar. 31, 2013

Condensed Financial Information Of Parent Company Only Disclosure [Abstract]

Schedule of consolidating balance sheets

OMEGA HEALTHCARE INVESTORS, INC.

CONSOLIDATING BALANCE SHEETS

Unaudited

(in thousands, except per share amounts)

	March 31, 2013
	Issuer & Subsidiary Guarantors			Non-Guarantor Subsidiaries			Elimination Company			Consolidated
Real estate properties
Land and buildings	$	2,475,194		$	571,611		$	—		$	3,046,805
Less accumulated depreciation		(560,768	)		(51,534	)		—			(612,302	)
Real estate properties – net		1,914,426			520,077			—			2,434,503
Mortgage notes receivable – net		240,551			—			—			240,551
		2,154,977			520,077			—			2,675,054
Other investments – net		48,537			—			—			48,537
		2,203,514			520,077			—			2,723,591
Assets held for sale – net		1,020			—			—			1,020
Total investments		2,204,534			520,077			—			2,724,611
Cash and cash equivalents		25,611			—			—			25,611
Restricted cash		6,675			27,702			—			34,377
Accounts receivable – net		122,435			7,823			—			130,258
Investment in affiliates		159,319			—			(159,319	)		—
Other assets		54,004			35,780			—			89,784
Total assets	$	2,572,578		$	591,382		$	(159,319	)	$	3,004,641
LIABILITIES AND STOCKHOLDERS’ EQUITY
Revolving line of credit	$	200,000		$	—		$	—		$	200,000
Secured borrowings		—			365,428			—			365,428
Unsecured borrowings – net		1,179,258			21,008			—			1,200,266
Accrued expenses and other liabilities		87,566			45,627			—			133,193
Intercompany payable		—			134,788			(134,788	)		—
Total liabilities		1,466,824			566,851		$	(134,788	)	$	1,898,887
Stockholders’ equity:
Common stock		11,615			—			—			11,615
Common stock – additional paid-in-capital		1,771,374			—			—			1,771,374
Cumulative net earnings		792,248			24,531			(24,531	)		792,248
Cumulative dividends paid		(1,469,483	)		—			—			(1,469,483	)
Total stockholders’ equity		1,105,754			24,531		$	(24,531	)		1,105,754
Total liabilities and stockholders’ equity	$	2,572,578		$	591,382		$	(159,319	)		3,004,641

	December 31, 2012
	Issuer & Subsidiary Guarantors			Non – Guarantor Subsidiaries			Elimination Company			Consolidated
ASSETS
Real estate properties
Land and buildings	$	2,466,866		$	571,687		$	—		$	3,038,553
Less accumulated depreciation		(535,223	)		(45,150	)		—			(580,373	)
Real estate properties – net		1,931,643			526,537			—			2,458,180
Mortgage notes receivable – net		238,621			—			—			238,621
		2,170,264			526,537			—			2,696,801
Other investments – net		47,339			—			—			47,339
		2,217,603			526,537			—			2,744,140
Assets held for sale – net		1,020			—			—			1,020
Total investments		2,218,623			526,537			—			2,745,160
Cash and cash equivalents		1,711			—			—			1,711
Restricted cash		7,078			29,582			—			36,660
Accounts receivable – net		118,473			6,707			—			125,180
Investment in affiliates		163,610			—			(163,610	)		—
Other assets		38,224			35,070			—			73,294
Total assets	$	2,547,719		$	597,896			(163,610	)	$	2,982,005
LIABILITIES AND STOCKHOLDERS’ EQUITY
Revolving line of credit	$	258,000		$	—		$	—		$	258,000
Secured borrowings		—			366,538			—			366,538
Unsecured borrowings – net		1,179,345			21,049			—			1,200,394
Accrued expenses and other liabilities		99,045			46,699			—			145,744
Intercompany payable		—			143,158			(143,158	)		—
Total liabilities		1,536,390			577,444			(143,158	)		1,970,676
Stockholders’ equity:
Common stock		11,239			—			—			11,239
Common stock – additional paid-in-capital		1,664,855			—			—			1,664,855
Cumulative net earnings		754,128			20,452			(20,452	)		754,128
Cumulative dividends paid		(1,418,893	)		—			—			(1,418,893	)
Total stockholders’ equity		1,011,329			20,452			(20,452	)		1,011,329
Total liabilities and stockholders’ equity	$	2,547,719		$	597,896		$	(163,610	)	$	2,982,005

Schedule of consolidating statement of operations

OMEGA HEALTHCARE INVESTORS, INC.

CONSOLIDATING STATEMENTS OF OPERATIONS

Unaudited

(in thousands, except per share amounts)

	Three Months Ended March 31, 2013
	Issuer & Subsidiary Guarantors			Non – Guarantor Subsidiaries			Elimination Company			Consolidated
Revenue
Rental income	$	77,641		$	15,468		$	-		$	93,109
Mortgage interest income		7,346			-			-			7,346
Other investment income – net		1,306			-			-			1,306
Total operating revenues		86,293			15,468			-			101,761
Expenses
Depreciation and amortization		25,575			6,384			-			31,959
General and administrative		5,082			115			-			5,197
Acquisition costs		134			-			-			134
Total operating expenses		30,791			6,499			-			37,290
Income before other income and expense		55,502			8,969			-			64,471
Other income (expense):
Interest income		(5	)		8			-			3
Interest expense		(20,774	)		(4,898	)		-			(25,672	)
Interest – amortization of deferred financing costs		(682	)		-			-			(682	)
Equity in earnings		4,079			-			(4,079	)		-
Total other expense		(17,382	)		(4,890	)		(4,079	)		(26,351	)
Net income available to common stockholders	$	38,120		$	4,079		$	(4,079	)	$	38,120

	Three Months Ended March 31, 2012
	Issuer & Subsidiary Guarantors			Non – Guarantor Subsidiaries			Elimination Company			Consolidated
Revenue
Rental income	$	63,964		$	12,011		$	-		$	75,975
Mortgage interest income		7,336			-			-			7,336
Other investment income – net		1,130			-			-			1,130
Miscellaneous		74			-			-			74
Total operating revenues		72,504			12,011			-			84,515
Expenses
Depreciation and amortization		21,899			5,248			-			27,147
General and administrative		5,414			112			-			5,526
Acquisition costs		105			-			-			105
Impairment loss on real estate properties		272			-			-			272
Total operating expenses		27,690			5,360			-			33,050
Income before other income and expense		44,814			6,651			-			51,465
Other income (expense):
Interest income		-			7			-			7
Interest expense		(19,107	)		(3,860	)		-			(22,967	)
Interest – amortization of deferred financing costs		(629	)		-			-			(629	)
Interest – refinancing costs		(7,108	)		-			-			(7,108	)
Equity in earnings		2,798			-			(2,798	)		-
Total other expense		(24,046	)		(3,853	)		(2,798	)		(30,697	)
Income before gain on assets sold		20,768			2,798			(2,798	)		20,768
Gain on assets sold – net		5,316			-			-			5,316
Net income available to common stockholders	$	26,084		$	2,798		$	(2,798	)	$	26,084

XML

STOCK-BASED COMPENSATION (Narrative) (Detail) 1	1 Months Ended			3 Months Ended	12 Months Ended	3 Months Ended	12 Months Ended	3 Months Ended	12 Months Ended		1 Months Ended	3 Months Ended
	Jan. 31, 2013 Performance restricted stock units Employees	Jan. 31, 2012 Performance restricted stock units Employees	Jan. 31, 2011 Performance restricted stock units Employees	Mar. 31, 2013 Performance restricted stock units Multi-year Absolute TSR	Dec. 31, 2011 Performance restricted stock units Multi-year Absolute TSR	Mar. 31, 2013 Performance restricted stock units Multi-year Relative TSR	Dec. 31, 2011 Performance restricted stock units Multi-year Relative TSR	Mar. 31, 2013 Performance restricted stock units Annual TSR Employees	Dec. 31, 2012 Performance restricted stock units Annual TSR Employees	Dec. 31, 2011 Performance restricted stock units Annual TSR	Jan. 31, 2011 Restricted stock Employees	Mar. 31, 2013 Restricted stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Performance based restricted stock granted, number of employees	6	6	6					6	6		6
Stock awards, vesting date												Dec. 31, 2013
Stock awards, vesting percent				25.00%		25.00%						100.00%
Number of shares granted	124,244	124,244	496,977		279,550		93,183	124,244	124,244	124,244	428,503
Stock awards, vesting year				2014		2014
Shares of stock vested									124,244
Shares forfeited										124,244

XML

BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES (Policies)

3 Months Ended

Mar. 31, 2013

Organization, Consolidation and Presentation Of Financial Statements [Abstract]

Accounts Receivable

Accounts Receivable
 

Accounts receivable includes: contractual receivables, effective yield interest receivables, straight-line rent receivables and lease inducements, net of an estimated provision for losses related to uncollectible and disputed accounts.  Contractual receivables relate to the amounts currently owed to us under the terms of our lease and loan agreements.  Effective yield interest receivables relate to the difference between the interest income recognized on an effective yield basis over the term of the loan agreement and the interest currently due to us according to the contractual agreement. Straight-line receivables relate to the difference between the rental revenue recognized on a straight-line basis and the amounts currently due to us according to the contractual agreement.  Lease inducements result from value provided by us to the lessee at the inception or renewal of the lease and will be amortized as a reduction of rental revenue over the non cancellable lease term. 

On a quarterly basis, we review our accounts receivable to determine their collectability.  The determination of collectability of these assets requires significant judgment and is affected by several factors relating to the credit quality of our operators that we regularly monitor, including (i) payment history, (ii) the age of the contractual receivables, (iii) the current economic conditions and reimbursement environment, (iv) the ability of the tenant to perform under the terms of their lease and/or contractual loan agreements and (v) the value of the underlying collateral of the agreement.  If we determine collectability of any of our contractual receivables is at risk, we estimate the potential uncollectible amounts and provide an allowance.  In the case of a lease recognized on a straight-line basis or existence of lease inducements, we generally provide an allowance for straight-line accounts receivable and/or the lease inducements when certain conditions or indicators of adverse collectability are present.

A summary of our net receivables by type is as follows:

	March 31, 2013			December 31, 2012
	(in thousands)
Contractual receivables	$	3,269		$	3,963
Effective yield interest receivables		4,121			3,576
Straight-line receivables		104,983			98,973
Lease inducements		18,465			19,307
Allowance		(580	)		(639	)
Accounts receivable – net	$	130,258		$	125,180

We continuously evaluate the payment history and financial strength of our operators and have historically established allowance reserves for straight-line rent adjustments for operators that do not meet our requirements.  We consider factors such as payment history and the operator’s financial condition as well as current and future anticipated operating trends when evaluating whether to establish allowance reserves.